AIIMS

OPD Appointment

OPD Appointment

OPD Appointment

ORBO Donor Pledge Form

ORBO Donor Pledge Form

ORBO Donor Pledge Form

Emergency Dashboard

Emergency Dashboard

Emergency Dashboard

Accessibility Control

Default Doctor Image

Prof.
Rajat Ray

Male

Affiliation

Professor and Chief & Member INCB
Department of
National Drug Dependence Treatment Centre

Prof Rajat Ray is Ex-Professor and Head of the Department of Psychiatry and First Chief, National Drug Dependence Treatment Centre (NDDTC) between 2003-2013.

Prof. ATUL AMBEKAR

Prof.
ATUL AMBEKAR

Male

MBBS, MD

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
atul.ambekar@gmail.com
atul.ambekar@aiims.edu

Field of Interest

  • Public Health Issues related to Alcohol and Drug Use
  • Opioid Substitution Therapy (OST) and Harm Reduction
  • Training and human resource development
  • Gender and drug use
  • Drug Policies and Programs
  • Epidemiology of drug use
  • Community based research to facilitate access to services
  • Use of Information and Communication Technology in addiction-related issues

Total number of publications till date: 185

  • Awarded, Meritorious Award for outstanding contribution for the prevention & control of Non-Communicable Diseases (NCDs), April 2022, National Resource Centre for Non- Communicable Diseases, Thiruvalla, Kerala and Alcohol and Drug Information Centre (ADIC)
  • Awarded “ Venus International Medical Award 2019 (VIMA 2019)” for Excellence in Psychiatry, April 2019
  • Awarded “JJ Memorial Oration on Mental Health”: Govt. Grant Medical College, Mumbai, January 2017 (Topic- Alcohol and Public Health: Impact and Solutions)
  • Winner of “ BMJ Awards South Asia 2016” for the category, “Non-Communicable Disease Initiative of the Year”, November 2016
  • Awarded Travel Grant (Scholarship) for the Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong (Oct 2019)
  • Awarded Travel Grant (Scholarship) for the Annual Conference of International Society for the Study of Drug Policy, Sydney, Australia, May 2016
  • Any other relevant information:

Nominated member

  • Inter-Ministerial committee on 'dual use' and illicit trafficking of prescription drugs and precursors - Narcotics Control Bureau, Ministry of Home Affairs, Government of India (2022-ongoing)
  • Expert Committee for Reviewing the Current Model for the Integrated Rehabilitation Centre for Addicts (IRCA) Under NAPDDR - Ministry of Social Justice and Empowerment, Government of India (2022-2023)
  • Subject Expert Committee (Psychiatry and Neurology) – Central Drug Standards Control Organization, Ministry of Health and Welfare, Government of India (2017 - ongoing)
  • Global Burden of Disease (GBD), India Mental Health Expert Group – Public Health Foundation of India(2017- ongoing)
  • National Technical Resource Group, Injecting Drug Use - National AIDS Control Organisation, Government of India (2013 - ongoing)
  • Project Selection Committee  for setting up of District De-Addiction Centres (DDACs) under National Action Plan for Drug Demand Reduction (NAPDDR) - Ministry of Social Justice and Empowerment, Government of India (2022-ongoing)
  • Honorary Fellow, School of Criminology, University of Hong Kong (2019-ongoing)
  • Expert committee on “Exploring the possibility of blocking of illicit use of ‘dual use’ precursor chemicals for the manufacture of narcotic drugs, psychotropic substances and new psychoactive substances”, - Ministry of Home Affairs, Government of India (2020-2021)
  • National Consultative Committee on Drug Addiction and Rehabilitation - Ministry of Social Justice and Empowerment, Government of India (2015-2020)
  • Expert Advisory Panel on Drug Dependence - World Health Organization (WHO), Geneva (2012 -2019)
  • Strategic Advisory Group to United Nations, IDU and HIV - UNAIDS, UNODC and WHO (2012-2016)
  • Chairperson, Addictive Disorders Speciality Section, Indian Psychiatric Society (2019-2021)
  • Punjab Drug Addiction Rehabilitation Board, Government of Punjab, India (2018 - 2021)
  • National Task Force for Integrating Mental Health in Comprehensive Primary Health Care – Ministry of health and Family Welfare, Government of India (2018-19)
  • Steering Committee for Alcohol Control and Health – Ministry of Health and Family Welfare, Government of India (2014-2016)
  • National Task Force on Drug Demand Reduction and Capacity Building –Ministry of Social Justice and Empowerment, Govt. of India (2011-12)
  • Governing Body, Rajkumari Amrit Kaur College of Nursing, Delhi University (2021 - ongoing)

Membership Of Professional Societies

  • Addiction Psychiatry Society of India (APSI) – Secretary General
  • American Society of Addiction Medicine (ASAM)
  • Asia Pacific Society for Alcohol and Addiction Research (APSAAR) – Board of Directors (2017-21)
  • Harm Reduction International (HRI)
  • Indian Association for Social Psychiatry (IASP) – Elected Member, Executive Council (2017-20)
  • Indian Association of Private Psychiatry (IAPP) – Member, National Advisory Board
  • Indian Psychiatric Society (IPS) – Member, Certification and course committee
  • International AIDS Society (IAS)
  • International Doctors for Healthier Drug Policies (IDHDP)
  • International Society for Substance Use Treatment & Prevention Professionals (ISSUP)
  • International Society for the Study of Drug Policy (ISSDP)
  • International Society of Addiction Medicine (ISAM) – Member, Board of Directors

Membership Of Editorial And Advisory Boards Of Academic Journals

International Consultancies / Expert Services

  • Developing an online training program on ‘Unhealthy Substance Use’ for Primary Care Physicians (for the NCD Academy platform on Mental Health Disorders). Consultancy for World Psychiatric Association (WPA) and American College of Cardiology (ACC) (2021)
  • Demonstration Project on Opioid Substitution with Buprenorphine at Myanmar.Community Partners International (with support fromUSAID and UNAIDS) (2019-ongoing)
  • Drafting thematic chapter of INCB Annual Report 2017 (“Treatment & rehabilitation of drug use disorders: Essential component of demand reduction”).International Narcotics Control Board (INCB), Vienna (2017)
  • Rapid Assessment of Drug Use Pattern in Sri Lanka.Alliance Regional Technical Support Hub South Asia and the National STD/AIDS Control Programme, Sri Lanka (2017-2018)
  • Developing (a) “Standard Policy and Practice Guidelines ” and “Training Manual” and (b) conducting training programmes for Counsellors. National Drug Law Enforcement Agency (NDLEA), Government of Nigeria andUNODC, Vienna (2015-2017)
  • Review of Methodology and data on estimates of Injecting Drug Users and HIV service-coverage for World Drug Report 2014.UNODC, Vienna, (2013-2014)
  • Developing a E-health portal on Problem alcohol use in India, [https://www.alcoholwebindia.in ]WHO, Geneva (2010-13)
  • National Drug Use Survey in Maldives. UNODC, Maldives Project Office (2011-2012)
  • Capacity Building on Methadone Maintenance Treatment for service providers from Nepal and Bangladesh.UNODC, ROSA (2010)
  • A Review of OST Programme of Nepal. UNODC, ROSA (2010)

National Consultancies / Expert Services

Training and Capacity Building Consultancies

Research and Evaluation Consultancies

Other Activities

  • Represented Ministry of Health and Family Welfare, Government of India as a part of Indian delegation at the Indo-US Counter Narcotics Working Group (CNWG) meeting, New Delhi, July 2022
  • Represented Ministry of Health and Family Welfare, Government of India as a part of Indian delegation at the Commission on Narcotic Drugs (CND), Vienna, Mar 2020, April 2021, March 2022, September 2022
  • In-charge (and initiated): Women Substance Use Clinic (every Saturday) at NDDTC, AIIMS.
  • In-charge (and initiated): Community Outreach Clinic, (focused on homeless substance users) Kotla Mubarakpur, New Delhi
  • In-charge: Implementation of the scheme “Strengthening Drug De-Addiction Programme: Establishing Drug Treatment Clinics (DTCs)”, Ministry of Health and Family Welfare, Government of India. Details at: http://dtc-scheme.in/
  • In-charge: Implementation of the scheme “Establishing Addiction Treatment Facilities (ATFs) in government hospitals in India”, Ministry of Social Justice and Empowerment, Government of India. Details at: https://atf-scheme.in/
  • Organizing Secretary for the 1st National Conference of Addiction Psychiatry Society of India (APSI) – ADDICON 2021, December 2021
  • Organizing Secretary for the National CME, “Emerging Issues in Substance Use Disorders”, AIIMS, New Delhi, July 2017
  • Organizing Secretary for the National CME, “Opioid Substitution Therapy: Policy and Practice”, AIIMS, New Delhi, April 2015
  • Chairperson, Website & IT Committee for the Global congress of International Society of Addiction Medicine (ISAM 2019)
  • Contributed towards developing the “Substance Use Treatment Unit (SUTU)” at AOD Hospital, Indian Oil Refinery, Digboi, Assam.

Awards and Honours

  • Awarded, Meritorious Award for outstanding contribution for the prevention & control of Non-Communicable Diseases (NCDs), April 2022, National Resource Centre for Non- Communicable Diseases, Thiruvalla, Kerala and Alcohol and Drug Information Centre (ADIC)
  • Awarded “ Venus International Medical Award 2019 (VIMA 2019)” for Excellence in Psychiatry, April 2019
  • Awarded “JJ Memorial Oration on Mental Health”: Govt. Grant Medical College, Mumbai, January 2017 (Topic- Alcohol and Public Health: Impact and Solutions)
  • Winner of “ BMJ Awards South Asia 2016” for the category, “Non-Communicable Disease Initiative of the Year”, November 2016
  • Awarded Travel Grant (Scholarship) for the Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong (Oct 2019)
  • Awarded Travel Grant (Scholarship) for the Annual Conference of International Society for the Study of Drug Policy, Sydney, Australia, May 2016
  • Any other relevant information:

Presentations made at scientific meetings/ conferences/ workshops (2017 onwards)

  • Opioid Substitution Treatment: Policy and legal considerations. Invited plenary presentation at the ADDICON 2022, Annual conference of Addiction Psychiatry Society of India (APSI), Bengaluru, 3 December 2022
  • Drugs and Children in the context of Right to a drug free childhood. Invited plenary presentation at the conference, “Children Matter” organized by the 4th wave foundation and world federation against drugs, Thiruvananthapuram, 17 Nov 2022
  • Laws and policies related to addiction treatment. Invited plenary presentation at the Annual conference of Indian Association of Private Psychiatry - Haryana, Solan 12 November 2022
  • Overview of drug use and addiction. Invited plenary presentation at the Annual conference of Indian Association of Private Psychiatry - Haryana, Solan 11 November 2022
  • How to address substance use in Mental health programs? Panel discussion as a part of Mental Health Forum 2022, organized by the World Health Organization (Geneva), 10 Oct 2022
  • Challenges in the meaningful involvement of civil society in drug policies. Symposium presentation at ISAM 2022 global congress, Malta, 5 Oct 2022
  • ISAM-GEN Structure and Expert Contact Points: From Individuals to Addiction Societies and Treatment Centers. (With Preethy K). Symposium presentation at ISAM 2022 global congress, Malta, 4 Oct 2022
  • Time for India to End Its War on Drugs? Panel discussion by “Argumentative Indians”, (online), 25 Sep 2022
  • Treatment of Opioid Dependence: Policy and Legal Considerations. CME organized by the Hyderabad Psychiatric Society, Hyderabad, 24 Sep 2022
  • Understanding Drug Use (and how to deal with it?). Online Training on Drug Law Enforcement, organized by National Academy of Customs, Indirect Taxes and Narcotics (NACIN), Mumbai, 20 Sep 2022
  • Laws and Policies related to Addiction Psychiatry. NationalWebinar presented for the resident doctors of National Board of Examination (DNB-Psychiatry), 14 Sep 2022
  • Substance Use and Suicide. Invited lectureat the Annual National Conference of Society for Rural Mental Health, Solan, 10 Sep 2022
  • Drug Use in India: What role could police play?, Training program Police Officers, Delhi Police Academy New Delhi, 8 Sep 2022
  • Harm Reduction: Concept, Philosophy and application to Tobacco. Round table organized by the Policy Circle, New Delhi 4 Sep 2022
  • Harm Reduction: Opioid Substitution Therapy and Needle Exchange Programs for people who inject drugs. Training program for medical and paramedical staff at Delhi Prisons, New Delhi, 24 August 2022
  • SUBSTANCE USE DISORDERS & BIPOLAR DISORDER: Assessment & Management. Invited lecture in the Post Graduate Development Program of Indian Psychiatric Society – North Zone, Srinagar, 21 August 2022
  • Substance Use Disorders & their treatment: Situation in India. Invited presentation in the panel discussion on World Mental Health Report 2022, India International Centre, New Delhi, 12 August 2022
  • Long Acting pharmacological options for opioid dependence: Effectiveness and Ethics. Webinar organized by the Indian Association of Biological Psychiatry (IABP), 5 August 2022
  • Drug Addiction & its treatment: Situation in India. Invited lecture at the conference on “Drug trafficking and National security”, Narcotics Control Bureau, Chandigarh, 31 July 2022
  • Cannabis: The Changing Landscape of Perception and Policies. Invited lecture at GPsyCon 2022, Annual conference of Goa Psychiatric Society, Goa, 23 July 2022
  • Drug Addiction situation & responses in India: Focus on North-East. Invited lecture at North East Police Coordination Committee meeting organized by DG police, Tripura, Agartala, 22 July 2022
  • Nasha – Ek Bimari. Ilaaj hai zaroori. Panel discussion organised by the Public Health Dept., Govt. of Maharashtra and Indian Psychiatric Society, West Zone, Mumbai, 17 July 2022, online
  • Drug Addiction & Drug Laws: The interface. ‘Core Competence Conference on Knowledge, Skills & Perspective Development for Special Judges – NDPS Act’, Delhi Judicial Academy, New Delhi, 16 July 2022
  • Treatment of Opioid Dependence: Policy and Legal Issues. CME on addiction psychiatry organized by AIIMS, Bhubaneswar, 10 July 2022
  • Indo-Us Enhanced cooperation related to substance use prevention, treatment and rehabilitation. Presented on behalf of MoH&FW, Govt. of India at India-US Counter-Narcotics Working Group (CNWG), meeting; New Delhi, 7 July, 2022
  • Facts about drug use and addiction. E-SYMPOISUM on Trends in Narcotic Drugs Psychotropic Substances, organized by the Forensic Science laboratory, Govt of Delhi; 27 June 2022; online
  • Recent Policy Update in Decriminalisation of Drug Use.  CME - 'Recent Advances in Addiction Psychiatry’ organized by AIIMS Jodhpur; 26 June 2022, online
  • Substance Use: Government Policies and Laws.  Capacity Building Program for Govt. college teachers (Assistant professor level) of social sciences; NDDTC AIIMS; Ghaziabad, 18 June 2022 
  • Substance Abuse & Alcohol Addiction: Deciphering its Impact on the Mental Health of Adolescents & Young Adults. Panel discussion (webinar) organized by the Asia Society India; 25 May 2022, online
  • Magnitude of drug use in India & our drug policies. Panel discussion on the occasion of inauguration of National Resource Centre on NCDs; 28 April 2022; Thiuvalla, Kerala.
  • Epidemiological research on substance use in India. Lessons from the field. Webinar on ‘Innovations in Addictions Research in India’ organized by Sangath, Goa; 21 April 2022; online
  • Substance Use: Attitudes, Policies and Stigma in India. Annual Conference of American Society of Addiction Medicine (ASAM), 15 April 2022; online
  • Use of addictive substances: Myths and facts. World Health Day event for students and resident doctors at AIIMS, New Delhi, 7 April 2022; New Delhi
  • Brief Interventions for Tobacco and Alcohol use disorders. 7th International Course on Public Health Approaches to Non-communicable Diseases (NCDs), organized by Centre for Community Medicine, AIIMS New Delhi in partnership with World NCD Federation and World Health Organization (WHO); 7 April 2022; New Delhi
  • NDPS Act and the Psychiatrist. Panel discussion moderated at the national CME during the Annual National Conference of Indian Psychiatric Society (ANCIPS); 24Mar 2022; Vishakhapatnam
  • Amendments in the NDPS Act. Panel discussion and workshop organized by the Department of Revenue, Min. of Finance, Government of India; 9 Mar 2022; New Delhi
  • Decriminalization of drug use- Need of the hour. CME organized by the Indian Psychiatric Society North Zone; 9 Feb 2022; Online
  • Drug Addiction among children. Training workshop organized by Narcotics Control Bureau (NCB), Govt of India and National Commission for protection of child rights (NCPCR); 8 Feb 2022; Online
  • Magnitude of drug use in India. Training workshop organized by Narcotics Control Bureau (NCB), Govt of India and National Commission for protection of child rights (NCPCR); 8 Feb 2022; Online
  • The International Scheduling System for Narcotic Drugs & Psychotropic Substances: Implications for South Asia. Conference of SAARC Psychiatric Federation (SPF), Kolkata, 18 December 2021
  • Newer Pharmacotherapies for treatment of opioid dependence: Evidence and Ethics. Annual meeting of Indonesian Psychiatric Association, 5 December 2021
  • The International Scheduling System for Narcotic Drugs & Psychotropic Substances: Does It Need an Overhaul?. Plenary lecture in ISAM 2021 Global congress, 21 Nov 2021
  • India: COVID19, Lockdown & Addiction Treatment. Symposium in ISAM 2021 Global congress 21 Nov 2021
  • Newer Pharmacotherapies for treatment of opioid dependence: A Critique. Annual conference of East Zone Indian Psychiatric Society 12 Nov 2021
  • Management of Alcohol Use Disorders in medical settings. Conference of IMA West Zone, 12 Oct 2021
  • Leveraging Information Technology for capacity building in Addiction Treatment. CME organized by IPS West Zone 9 Oct 2021
  • Newer Pharmacotherapies for treatment of opioid dependence: Evidence and Ethics. Annual conference by UP IPS, 25 Sep 2021
  • E-Health Screening & Brief Interventions: Implications for LAMI countries. Plenary lecture in INEBRIA conference, 24 Sep 2021
  • The Genesis of APSI. Symposium presented in WASP 2021, 16 Sep 2021
  • ICD – 11 classification for substance use and addictive behaviors. National CME organized by PGIMER Chandigarh, 15 Sep 2021
  • Opioid Dependence: An overview of management. National Workshop organized by Dept of Addiction Medicine, LGBRIMH, Tezpur, 4 Sep 2021
  • Substance Use Disorders: A public health concern. Guest lecture (online) delivered for the faculty and students from Armed Forces Medical College (AFMC), Pune, 12 August 2021
  • Facts about drugs and addiction. Lecture delivered to the senior officials on Sashastra Seema Bal (SSB), on the occasion of International Day against Drug Abuse and Illicit Trafficking, 30 June 2021
  • National Policies and Programmes on treatment of substance use disorders. Webinar organized by the Nursing Division, Ministry of Health and Family Welfare, Govt. of India on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021
  • The International Framework for Drug Control. Webinar organized by the Central Institute of Psychiatry (CIP) on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021
  • Laws and Policies related to Addiction Psychiatry. Online CME organized by AIIMS, Nagpur on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021
  • Opioid Agonist Treatment: Evidence for effectiveness in Opioid Use Disorders. Webinar organized by the Institute of Mental Health and Neurosciences, GMC, Srinagar J&K, on the occasion of International Day against Drug Abuse and Illicit Trafficking, 25 June 2021
  • Why India does not have an overdose crisis (so far)? Workshop delivered (online) in the International conference ‘Let’s talk overdose’ organized by the University of British Columbia, Vancouver, Canada, 23 June 2021
  • India, COVID19 and Addictions. International conference on Technology Addiction, organized by Turkish Green Crescent Society, online, 2 June 2021
  • Cannabis: the changing landscape of perceptions and policies. CME of Indian Psychiatric Society – South Zone, online – 24 April 2021
  • Addiction treatment services duringCOVID19 in India. Side event during the CND meeting (virtual), organized by the International Doctors on Healthier Drug Policies (IDHDP) – 12 April 2021
  • Addictions To Cyberspace & Their Management. Delivered at CME organized by the Indian Psychiatric Society – West Zone, Online – 11 April 2021
  • Brief interventions and MET in substance use disorders. ‘Thursday Musings’ webinar series organized by the Indian Psychiatric Society – Odisha branch, 18 March 2021 
  • Treatment of Substance Use Disorders. National Webinar on ‘Dimensions of Social Defence & Linkages with SDGs’ organized by the FORE school of management, 24 February 2021
  • Epidemiology of Substance Use. PG Development program organized by the Indian Psychiatric Society – Central Zone, 20 February 2021
  • Drug Addiction: An overview and strategies for management. Forensic and Technical Course on Narcotic Drugs and Psychotropic Substances for Sri Lankan Police officers, organized by the Central Academy of Police Training, 12 February 2021
  • Newer Technologies for treatment of opioid dependence: Evidence and Ethics. Annual National conference of Indian Association of Biological Psychiatry, 7 February 2021
  • ICD-11 Disorder related to Substance Use and Addictive Behaviour: Field Trial India. National CME organized by the Addiction Psychiatry Society of India (APSI), 31 January 2021
  • Harm Reduction: Concept, Philosophy and application to Tobacco. Webinar organized by the Association for Harm Reduction Education and Research, 19 January 2021
  • Cannabis Policies: The Way forward. Webinar organized by Indian Psychiatric Society, West Bengal, 17 January 2021
  • Evidence Based Treatment of Cannabis Dependence. Webinar organized by the Behavioural and Neuroscience Academy of India, 5 January 2021
  • COVID19 pandemic: Impact on Addiction Psychiatry. Annual National Conference of Indian Association of Private Psychiatry, 5 December 2020
  • Opioid Use Epidemic in India: Changing Pattern and Policy Implications. Keynote address delivered in the ISAM Asia Regional conference, 5 December 2020
  • Medicolegal issues with reference to NDPS & MHCA in management of Substance Use Disorders. Webinar organized by Indian Psychiatric Society, 27 October 2020
  • Public health and addictive drugs: Laws and Policies: What works and What doesn’t. Webinar organized by Meghalaya legal services authority and Government of Meghalaya on Mental health day, 9 October 2020
  • SUBSTANCE USE IN NAGALAND. State level consultation organized by Kripa Foundation, Nagaland, 4 August 2020
  • Laws and Policies related to Addiction Psychiatry. Webinar organized by Kolkata Psychiatry Club and Indian Psychiatric Society, West Bengal. 26 July 2020
  • Opioid Substitution Treatment : An Overview. Webinar organized by Indian Psychiatric Society, Odisha, 26 July 2020
  • Benzodiazepine use disorders in clinical practice. Webinar organized by the Indian Psychiatric Society, Karnataka Chapter, 2 July 2020
  • India: COVID19, Lockdown and Addictions. Webinar organized by Govt. of NCT of Delhi, 26 June 2020
  • India: COVID19, Lockdown and Addictions. Webinar organized by International Society of Addiction Medicine, 20 May 2020
  • Services for Drug Use among youth. Moderated the Panel Discussion, during the Indo Scotland Mental Health Conclave, New Delhi, 29 January 2020
  • Alcohol: Evidence for impact of Prohibition. National Conference ‘From Neurons to Neighbourhood’, by Sun Pharma Research Foundation, New Delhi, 27 January 2010
  • Magnitude of drug use in India and the existing policy and program framework for response: A road map for evidence-informed drug supply control and demand reduction, Symposium deliveredat the Annual National Conference of Indian Psychiatric Society (ANCIPS), Kolkata, 24 January 2020
  • Behavioural Addiction: A Primer for Mental Health Professionals, workshop conducted at the National CME during the Annual National Conference of Indian Psychiatric Society (ANCIPS), Kolkata, 22 January 2020
  • Pharmaceutical drug addiction. Training workshop for Police officers from Sri Lanka, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 20 January 2020
  • Classification of Psychoactive Substances: Based on Science? CME of Addictive Disorder Specialty section, Indian Psychiatric Society, Mumbai, 5 January 2020
  • Substance Use Disorders: An Overview. Workshop for undergraduate Medicalstudents of Rajasthan, Jaipur, 21 December 2019
  • Opioid Substitution Treatment: An Overview. National Consultation on OST, Yangon, Myanmar, 11 December 2019
  • Long term pharmacotherapy for alcohol use disorders. CME of Indian Psychiatric Society, West Zone, Goa, 7 December 2019
  • Pharmaceutical drug use disorders. Training workshop for Drug Law Enforcement officers from Afghanistan, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 5 December 2019
  • Debate: OST is the most evidence-based, ethical and appropriate treatment for opioid dependence (For). PSCHIATRICKS, New Delhi, 24 November 2019
  • Drug Laws and Policies: International trends. Annual Conference of Indian Psychiatric Society, North Zone, Amritsar, 3 November 2019
  • Concept and Philosophy of Drug Harm Reduction: Application in India. Stakeholder consultation on substance use harm reduction, Knowledge Action Change, New Delhi, 17 October 2019
  • A Road map for evidence informed drug supply control response in India. Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong, 15 October 2019
  • Drug Use Situation in India. Conference on Comprehensive Approach to Combating Illicit Trafficking of Afghan Opiates and Drug Situation in North East, Imphal, 30 September 2019
  • Drug Policy responses in India. Asian Regional Forum Against Drugs, Kochi, 25 September 2019
  • Outpatient management of Opioid Dependence. Annual National Conference of Indian Association for Biological Psychiatry, Agra, 20 September 2019
  • Drug Testing: A new harm reduction intervention at the interface of Toxicology and Addiction Psychiatry. Conference of Indian Association of Medico Legal Experts and Medico Legal Conference Nepal, Kathmandu, 13 September 2019
  • Integrated Package Of Services For Injecting Drug Users. National consultation organized by NACO, Govt. of India, New Delhi, 3 September 2019
  • Size estimation of Injecting Drug Users in India. Meeting of Technical Experts organized by NACO, Govt. of India, 26 August 2019
  • Substance Use and Sexual Dysfunction. National Mid Term CME of Indian Psychiatric Society, Mysore, 10 August 2019
  • Substance Use situation in India: evidence-informed prevention strategies. National workshop on Substance Use Prevention for State Council of Education Research and Training (SCERTs), New Delhi, 2 August 2019
  • Drug Use in India: What role could police play?, Orientation program on National Action Plan for Police key coordinators, New Delhi, 18 June 2019
  • Preventing Substance Use: What Works, What doesn’t. AnnualCME of Indian Psychiatric Society – West Zone, Nashik, 27 April 2019
  • Magnitude of Substance Use in India. Regional Consultation on Drug Use organized by United Nations Office on Drugs and Crime, New Delhi, 24 April 2019
  • Epidemiology of Substance Use in India. CME of Society for Rural Mental Health, Hisar, 21 April 2019
  • National Drug Use Survey: “Magnitude of Substance Use in India”. Annual Meeting of Narcotics Coordinaton NARCORD, Ministry of Home Affairs, New Delhi 12 March 2019
  • Preventing Substance Use: What Works, What doesn’t. Annual Psychology Festival, Aryabhata College, Delhi University, New Delhi, 1 March 2019
  • Magnitude of Substance Use in India. National Conference of Principle Secretaries of State Governments, organized by MoSJE, Govt. of India, 26 February 2019
  • Drug Use situation in India. training programme for Drug Law Enforcement officers from NCB, National Academy of Customs, Indirect Tax and Narcotics (NACIN), New Delhi, 25 February 2019
  • Magnitude of Substance Use in India. Panel Discussion on ‘10 years of Drug Policy in Asia: How far we have come?’ New Delhi, 20 February 2019
  • Drug Abuse scenario in India, vulnerable population and treatment services. Interactive Workshop under National Action Plan for Drug Demand Reduction organized by the National Institute of Rural Development & Panchayati Raj, Hyderabad, 1 February 2019
  • Management of Opioid Dependence. CME update organized by the Jammu and Kashmir Psychiatric Society, Jammu, 18 January 2019
  • Drug Use and HIV: Interface with Law enforcement: National Consultation with Police Training Academies, Organized by NACO, Govt. of India, New Delhi, 10 January 2019
  • Opioid Pharmaceuticals: Policy and legal issues. Indian Pharmaceutical Congress, NOIDA, 22 December 2018
  • Policy and legal issues related to Opioid analgesics in palliative care and addiction treatment. Workshop “opioids in palliative care” organized by FDA, Punjab, Chandigarh, 18 Dec 2018
  • Preventing Substance Use: What Works, What Doesn’t. National CME of Preventive Psychiatry Section of Indian Psychiatric Society, Patna, 8 December 2018
  • Abuse of Pharmaceutical drugs in India. training programme for Drug Law Enforcement officers from Myanmar, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 6 December 2018
  • Opioid Substitution Treatment (OST) is the Best strategy for management of Opioid Use Disorders. (Debate – For). National Conference of Indian Association of Private Psychiatry (ANCIAPP), Hyderabad, 1 December 2018
  • Intervention Strategies for Alcohol Use Disorders. National Conference of Indian Society of Gastroentrology, Kochi, 30 November 2018
  • Drug Laws and Policies. What Works and What Doesn’t. Law Economics Policy Conference (LEPC 2018), organized by the National Institute of Public Finance and Policy (NIPFP), New Delhi, 27 November 2018
  • Addiction in North East: Opportunities, Challenges and the way forward. North East Health Care Leadership Summit 2018, Shillong, 29 October 2018
  • Mental Health Care Act (MHCA) 2017: Implications for Addiction Treatment in India. Annual Conference of Indian Psychiatric Society – Rajasthan State, Bikaner, 20 October 2018
  • Treatment of Opioid Dependence: Policy and Legal Issues. National conference of Society for Rural Mental Health, Karnal, 29 September 2018
  • Pharmaceutical drug use – South Asia, training programme for officers from Department of Narcotics Control, Bangladesh, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 26 September 2018
  • Drug Laws and Policies: Scientific arguments for criminalization and De-Criminalization. training programme for judiciary, Delhi Judicial Academy, 15 September 2018
  • Sleep and Opioids: Neurobiology and clinical aspects. Global Conference of Biological Psychiatry, Mumbai, 25 August 2018
  • Changing legal and policy scenario for drugs: Implications for Psychiatrists. Mid Tem CME of IPS East Zone, Dibrugarh, 18 August 2018
  • Cannabis: From Neurobiology to Policy. Mid Tem CME of IPS East Zone, Dibrugarh, 18 August 2018
  • Data collection and analysis for Drug Use Epidemiology: An overview. Training Programme on “Planning and Designing of large scale sample surveys” for officers of Indian Statistical Service, National Statistical Systems Training Academy (NSSTA), Greater Noida, 19 June 2018
  • Economic Cost (and benefit) of Scale-up of Opioid Substitution Treatment in National AIDS Control Program, India: Comparison of three scenarios. Conference of International Society for the Study of Drug Policy (ISSDP 2018), Vancouver, Canada, 17 May 2018
  • Cannabis: The Final Word, RISE 2018, organized the Behavioural and Neurosciences Academy of India, Goa, 11 May 2018
  • National Drug Use Survey: An Overview. Delivered at National Conference of Drug Law Enforcement agencies, 24 March 2018, New Delhi
  • Alcohol Use Disorder: Demand Reduction Strategies. Delivered at South East Asia Region course on Public Health Approaches for Non-Communicable Disease, 21 March 2018, New Delhi
  • Opioid Substitution Treatment: An Overview of Theory and Evidence Base, Workshop organized by National STD AIDS Control Program, Government of Sri Lanka, Colombo, 27 February 2018
  • An Overview of Drug Use Disorders. Training programme for Drug Law Enforcement officers from Government of Myanmar, Narcotics Control Bureaue, New Delhi, 23 February 2018
  • Pharmaceutical drug use – South Asia, training programme for officers from Department of Narcotics Control, Bangladesh, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 13 December 2017
  • Drug Use Epidemiology: Methodological Issues. Training Programme on “Advanced Sampling Techniques” for officers of Indian Statistical Service, National Statistical Systems Training Academy (NSSTA), Greater Noida, 7 Dec 2017
  • Co-morbid Cannabis Use Disorder and Gaming Disorder, Fourth WHO meeting on Public health Implications of Addictive Behaviors, Istanbul, Turkey, 1 December 2017
  • Trends in Drug Laws and Policies. National Conference of Addiction Psychiatry, AIIMS, New Delhi, 27 November 2017
  • Issues related to Pharmaceutical drugs Abuse, training programme for Drug Law enforcement officers from Tanzania, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 10 November 2017
  • Cannabis Dependence: Neurobiology and treatment approaches. Annual Conference of Indian Association for Biological Psychiatry, Chandigarh, 19 August 2017
  • Beyond Alcohol: Issues and Strategies, meeting of Indian Psychiatric Society, Bihar (in the wake of alcohol prohibition), Patna, 24 July 2017
  • Alcohol Control: Identifying opportunities for civil society action in the current policy context. National Civil Society Consultation on Non-Communicable Diseases (NCDs) in India, New Delhi, 11 July, 2017
  • Abuse of Pharmaceutical drugs, training programme for Drug Law enforcement officers, National Academy of Customs, Excise and Narcotics (NACEN), Faridabad, 31 May 2017
  • Do drug policies impede the availability of treatment of opioid dependence in India (and more so for non-injecting opioid users)? Analysis of epidemiological data from Punjab, India, International Society for the Study of Drug Policy Conference 2017 (ISSDP 2017), Aarhus, Denmark, 16 May 2017
  • Can economic analysis of household income and expenditure inform alcohol policies? Analysis of household data from nationally representative sample from India, International Society for the Study of Drug Policy Conference 2017 (ISSDP 2017), Aarhus, Denmark, 17 May 2017
  • Managing Pain in Palliative care with Opioids: Perspective of an Addiction Treatment Provider, Annual Conference on Indian Association of Palliative Care, Coimbatore, 11 February 2017
  • Alcohol and Public Health: Impact and Solutions. JJ Memorial oration on mental health, delivered at Govt. Grants Medical College, Mumbai, 24 January 2017
  • National Survey on Extent and Pattern of Substance Use in India: Methodology and Operational Issues, Annual National Conference of Indian Psychiatric Society, Raipur, 6 Jan 2017

Investigator/ Co-investigator in funded projects along with year completed/ongoing

As Principal Investigator

  • National Survey on Extent and Pattern of Substance use in India, Supported by the Ministry of Social Justice and Empowerment, Government of India (2016-2021)
  • Development and evaluation of service delivery models for management of substance use disorders among the homeless population receiving urban shelter services in Delhi, Supported by the Department of Women and Child Development, Government of NCT of Delhi (2021 – ongoing)
  • Establishing Addiction Treatment Facilities in Government Health care settings, Supported by the Ministry of Social Justice and Empowerment, Government of India (2019-ongoing)
  • Field Testing of ICD-11 Classification for Disorders related to Substance Use and Addictive Behaviours, Supported by WHO (Geneva), (2018-2020)
  • Developing Training Mechanisms for use of Essential Narcotic Drugs (Methadone) for the treatment of Opioid Dependence, Supported by the Dept. of Revenue, Government of India (2017 – ongoing)
  • Effectiveness of the revised version of DrinkLess – A Web based self help intervention to reduce alcohol consumption in harmful hazardous drinkers: A Transnational RCT. Supported by World Health Organization (Geneva). (2016-ongoing)
  • Punjab Opioid Dependence Survey, supported by the Society for Promotion of Youth and Masses (SPYM), with financial support from Ministry of Social Justice and Empowerment, Government of India (2014 – 2015)
  • Development of an online training programme on Opioid Substitution Therapy, Project supported by Public Health Foundation of India (2014 – 2017)
  • Post Marketing Surveillance of Methadone in India, Project supported by the Rusan Pharma (2013 – 2014)
  • Drug Use Pattern Assessment in Bihar, Haryana and Uttarakhand, project supported by India HIV/AIDS Alliance and NACO (2013 – 2014)
  • Opioid Substitution Therapy under the National AIDS Control Program: A situation Assessment, supported by GFATM Round 9 grant and NACO, 2012
  • Risk of Transition to Injecting Drug Use among non-injecting opioid users: A Multi-site study in Northwest India, supported by Regional Resource Training Centre, MoSJE, Government of India (2012)
  • A pilot study of feasibility and efficacy of Brief intervention compared with Simple Advice when linked to the Brief ASSIST for Substance Use Disorders in Primary Health Care and Community Settings: Project of University of Adelaide, WHO Collaborating Centre, (2011)

As Co-Investigator

  • Experience of Patients on Methadone Maintenance Treatment receiving Take-Home Methadone doses during COVID-19 pandemic In India: A mixed-method study. Investigators:Ravindra Rao, Atul Ambekar, Rakesh Chadda, Alok Agrawal, Roshan Bhad (2021 – ongoing)
  • Establishing and Implementing Capacity Building Mechanisms for Addiction Treatment Facilities in India Investigators: Alok Agrawal, Atul Ambekar, Rakesh Chadda, Roshan Bhad, Ravindra Rao, (2019-ongoing)
  • Field Testing of International Standards for Treatment of Drug Use Disorders, Investigators: Rakesh Chadda, Atul Ambekar, Roshan Bhad, Ravindra Rao, Alok Agrawal (2017 – 2019)
  • Rapid Assessment of Drug Use Patterns (RADUP) among People Who Use and/or Inject Drugs (PWUD/PWID) in Sri Lanka, Investigators: Sathya Herath, Atul Ambekar (2017-2018)
  • Mapping and size estimation of drug using street children in Delhi. Investigators: Anju Dhawan, Atul Ambekar, Ashwani Mishra, Rachna Bhargava, Biswadip Chatterjee, Alok Agrawal, 2015 – 2016
  • Workplace intervention for Drug and Alcohol use at Indian Oil Refinery, Digboi, Assam, Investigators: Prof Rajat Ray, Atul Ambekar, Rakesh Lal, Deepak Yadav (2010-ongoing)
  • Methadone Maintenance Treatment in India: A multi-site feasibility and effectiveness study. Investigators: Anju Dhawan, Atul Ambekar, Rajat Ray, Deepak Yadav, Anita Chopra, Raka Jain 2011 – 2014
  • OST program in Government health-care settings: treatment compliance and retention’, Investigators: Deepak Yadav, Atul Ambekar, Anju Dhawan, Alok Agrawal, Jyoti Mehra, Hem Sethi, report submitted to DFID TAST and NACO, Government of India
  • Mapping and size estimation of High Risk Groups in Jammu and Kashmir and Tripura, in collaboration with Society for Promotion of Youth and Masses, New Delhi, conducted for and report submitted to National AIDS Control Organisation (NACO), New Delhi, 2008
  • A Rapid situation assessment of inhalant use among street children in Delhi and development of an intervention, Investigators: Rajat Ray, Anju Dhawan, Atul Ambekar, Deepak Yadav, Anita Chopra, 2008-2009
  • Developing community-based drug treatment services at four districts in the country – Mandsaur, MP, Bilaspur, Chattisgarh, Meerut, UP and Morigaon, Assam, Investigators: Rajat Ray, Atul Ambekar, Rakesh Lal, Deepak Yadav, Anita Chopra, 2008-2013

Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

Thesis supervised for MD/ DM/PhD

- as guide: 12

-as co-guide: 23

Details of publications since 2010 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications):

Papers And Articles (In Peer Reviewed Scientific Journals)

  • Teck JTW, Zlatkute G, Perez A, Dritschel H, Ghosh A, Potenza MN, Ambekar A, Ekhtiari H, Stein D, Khazaal Y, Arunogiri S, Torrens M, Ferri M, Galea-Singer S, Baldacchino A. Key implementation factors in telemedicine-delivered medications for opioid use disorder: a scoping review informed by normalisation process theory. Lancet Psychiatry. 2023 Jan;10(1):50-64. 
  • Forget P, Patullo C, Hill D, Ambekar A, Baldacchino A, Cata J, et al (2022). System-level policies on appropriate opioid use, a multi-stakeholder consensus. BMC Health Serv Res. 2022 Mar 12;22(1):329. doi: 10.1186/s12913-022-07696-x
  • Ambekar A (2022). Decriminalisation of drug use in India: A long overdue legal reform (editorial). Ind J Soc Psy. 2022, 38(3): 209-212. DOI: 10.4103/ijsp.ijsp_183_22
  • Ambekar A, Gautam M, Matcheswalla Y, Kar S, Kadam K (2022). Medicolegal Issues with Reference to NDPS and MHCA in Management and Rehabilitation of Persons with Substance Use Disorders. Indian J Psychiatry 2022 Mar;64(Suppl 1):S146-S153. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_724_21
  • Quraishi R, Varshney M, Rao RV, Ambekar A (2022). Evaluation of alcohol use pattern among OST patients using alcohol biomarkers: Report from community clinics in India. Indian J Psychiatry 2022 May-Jun;64(3):312-315
  • Singh R, Gupta R, Grover T, Ambekar A, Jain R, Vaswani M, Mishra A, Sharma A. Role of the Serotonin and GABAA Receptor Gene Polymorphisms in patients with Alcohol Dependence. Asian J Psychiatry,  2022 Nov 12;80:103326. doi: 10.1016/j.ajp.2022.103326.
  • Quraishi R, Sarkar S, Parmar A, Jain R, Das BK, Ambekar A (2022). Exploring the clinical variables among drug-dependent HIV-Positive patients: Implications for treatment strategies. Indian J Public Health 2022 Jul-Sep;66(3):331-333.
  • Choudhary N, Singh S, Rathore P, Ambekar A, Bhatnagar S (2021). Opioid Use Disorders among patients on long-term morphine for management for chronic cancer pain: A pilot study from a tertiary palliative care facility. Indian Journal of Palliative Care, 27(2); 264-268
  • Saini R, Parmar A, Rao R, Mishra AK, Ambekar A, Agrawal A (2021). Psychiatric and Substance Use Comorbidities among People who Inject Drugs in India: A Cross-Sectional, Community-Based Study. World Soc Psychiatry 2021;3:195-202.
  • Singh A, Rao R, Chatterjee B, Mishra AK, Kaloiya G, Ambekar A (2021). Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study, Asian Journal of Psychiatry, 61, 102697, https://doi.org/10.1016/j.ajp.2021.102697
  • Singh et al (India State-Level Disease Burden Initiative Neurological Disorders Collaborators) (2021). The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019. The Lancet Global Health, https://doi.org/10.1016/S2214-109X(21)00164-9
  • Schaub MP, Tiburcio M, Martínez-Vélez N, Ambekar A, Bhad R, Wenger A, Baumgartner C, Padruchny D, Osipchik S, Poznyak V, Rekve D, Landi Moraes F, Monezi Andrade AL, Oliveira Souza-Formigoni ML; WHO E-Health Project On Alcohol And Health Investigators Group (2021).  The Effectiveness of a Web-Based Self-Help Program to Reduce Alcohol Use Among Adults With Drinking Patterns Considered Harmful, Hazardous, or Suggestive of Dependence in Four Low- and Middle-Income Countries: Randomized Controlled Trial. J Med Internet Res. 2021 Aug 27;23(8):e21686. doi: 10.2196/21686.
  • Quraishi R, Sharma J, Jain R, Ambekar A (2021). Influence of catechol‑O‑methyltransferase enzyme gene polymorphism on alcohol and tobacco consumption in North Indian treatment seeking population. Indian J Psychiatry 2021;63:240-4
  • Manomy PA, Yenamandra VK, Dabas G, Joshi P, Ambekar A, Sreenivas V, Sharma VK, Vatsa M, Ravindran S, Sethuraman (2021). Impact of a psychodermatological education package on the subjective distress, family burden, and quality of life among the primary caregivers of children affected with epidermolysis bullosa. Indian Dermatol Online J 2021;12:276-80.
  • Chawla N, Verma S, Ganesh R, Sarkar S & Ambekar A (2021). Sexual relationship, self-esteem, dysfunction, and sexual satisfaction in treatment naïve men with heroin dependence. Journal of Psychoactive Drugs, doi.org/10.1080/02791072.2020.1870779
  • Castro‐Calvo, J., King, D. L., Stein, D. J., Brand, M., Carmi, L., Chamberlain, S. R., Demetrovics, Z., Fineberg, N. A., Rumpf, H.‐J., Yücel, M., Achab, S., Ambekar, A., Bahar, N., Blaszczynski, A., Bowden‐Jones, H., Carbonell, X., Chan, E. M. L., Ko, C.‐H., de Timary, P., Dufour, M., Grall‐Bronnec, M., Lee, H. K., Higuchi, S., Jimenez‐Murcia, S., Király, O., Kuss, D. J., Long, J., Müller, A., Pallanti, S., Potenza, M. N., Rahimi‐Movaghar, A., Saunders, J. B., Schimmenti, A., Lee, S.‐Y., Siste, K., Spritzer, D. T., Starcevic, V., Weinstein, A. M., Wölfling, K., and Billieux, J. (2021) Expert appraisal of criteria for assessing gaming disorder: An international Delphi study. Addiction, https://doi.org/10.1111/add.15411.
  • Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A; ISAM-PPIG Global Survey Consortium, Potenza MN, Ekhtiari H, Baldacchino AM (2021). Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Front Psychiatry. 2021 Apr 29;12:639393. doi: 10.3389/fpsyt.2021.639393. PMID: 34025471; PMCID: PMC8135096.
  • Farhoudian A, Radfar SR, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Khojasteh Zonoozi A, De Jong CAJ, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Hansen H, Brady KT; ISAM Global Survey Consortium (ISAM-GSC), Potenza MN, Baldacchino AM, Ekhtiari H (2021). A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic.Front Psychiatry. 2021 Aug 6;12:646206. doi: 10.3389/fpsyt.2021.646206. PMID: 34421664; PMCID: PMC8377291.
  • Mohan, A., & Ambekar, A. (2020). Telepsychiatry and Addiction Treatment.Indian Journal of Psychological Medicine, 42(5_suppl), 52S-56S. https://doi.org/10.1177/0253717620958169
  • Sartaj D, Krishnan V, Rao R, Ambekar A, Dhingra N, Sharan P. (2020). Mental illnesses and related vulnerabilities in the Hijra community: A cross-sectional study from India.Int J Soc Psychiatry. 2020 Aug 20:20764020950775. doi: 10.1177/0020764020950775.
  • Gupta R, Grover S, Basu A, Krishnan V, Tripathi A, Subramanyam A, Nischal A, Hussain A, Mehra A, Ambekar A, Saha G, Mishra KK, Bathla M, Jagiwala M, Manjunatha N, Nebhinani N, Gaur N, Kumar N, Dalal PK, Kumar P, Midha PK, Daga R, Tikka SK, Praharaj SK, Goyal SK, Kanchan S, Sarkar S, Das S, Sarkhel S, Padhy SK, Sahoo S, Satyanarayana Rao TS, Dubey V, Menon V, Chhabra V, Lahan V, Avasthi A (2020). Changes in sleep pattern and sleep quality during COVID-19 lockdown.Indian J Psychiatry. 2020 Jul-Aug;62(4):370-378. doi: 10.4103/psychiatry.IndianJPsychiatry_523_20
  • Grover T, Gupta R, Arora G, Bal CS, Ambekar A, Basu Ray S, Vaswani M, Sharma A (2020).Dopamine transporter availability in alcohol and opioid dependent subjects - a 99m Tc-TRODAT-1SPECT imaging and genetic association study.Psychiatry Res Neuroimaging. 2020 Sep 10;305:111187. doi: 10.1016/j.pscychresns.2020.111187
  • Dhagudu, N.K., Ambekar, A., Agrawal, A., Rao, R., Mishra, A.K., Jain, R. and Singh, S (2020). Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects.Drug Alcohol Rev. 2020; 39: 595-603 doi:10.1111/dar.13057
  • Sagar R et al (India State-Level Disease Burden Initiative Mental Disorders Collaborators) (2020). The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990–2017,The Lancet Psychiatry; 7 (2): 148-161
  • Rao R, Panda U, Gupta SK, Ambekar A, Gupta S, Agrawal A (2020). Portrayal of alcohol in Bollywood movies: A mixed methods study.Indian J Psychiatry, 62(2): 159-166
  • Goyal SG, Ambekar A, Jain R, Mehta M, Mishra AK (2020). Intravenous buprenorphine does not impair psychomotor and cognitive functioning in opioid-dependent patients using oral dextropropoxyphene: A randomized, double-blind, crossover study.J Mental Health Hum Behav 2020;25:45-52
  • Chawla N, Verma S, Sarkar S, Ambekar A (2020). Assessment of sexual behavior among patients seeking treatment for opioid dependence and their knowledge and attitude about high-risk sexual behavior: A cross-sectional observational study.Indian J Soc Psychiatry 2020;36:29-36
  • Vishwakarma A, Tarwani J, Chawla N, Dayal P, Agrawal A, Mandal P & Ambekar A (2020) Mephentermine dependence with induced psychosis: a series of two cases, Journal of Substance Use, 25:6, 569-571, DOI: 10.1080/14659891.2020.1749949
  • Rao R, Gupta SK, Swaminathan P, Gupta V, Dhawan A, Agrawal A & Ambekar A (2020) Predictors of long-term retention on opioid agonist treatment with buprenorphine: a 6-year, community-based retrospective cohort study in India, Journal of Substance Use, 25:5, 489-494, DOI: 10.1080/14659891.2020.1736666
  • Gupta S, Lal R, Ambekar A, Mishra AK, Rao R (2020). The pattern of alcohol use and its relationship with consequences among problem alcohol users: A community-based cross-sectional study from India. Indian J Psychiatry. 2020;62(2):152‐158. doi:10.4103/psychiatry.IndianJPsychiatry_194_19
  • Srivastava P, Mehta M, Sagar R, Ambekar A. Smartteen- a computer assisted cognitive behavior therapy for Indian adolescents with depression- a pilot study. Asian J Psychiatr. 2020;50:101970. doi:10.1016/j.ajp.2020.101970
  • Dhawan A, Mishra AK, Ambekar A, Chatterjee B, Agrawal A, Bhargava R (2020). Estimating the size of substance using street children in Delhi using Respondent-Driven Sampling (RDS),Asian Journal of Psychiatry: 48 (2020) 101890
  • Ambekar A, Mishra A, Parmar A, Kumar R, Kumar M, Rao R, Agrawal A (2019), Are non-injecting opioid users at risk of transition to injecting drug use? A multi-site study from India Asian Journal of Psychaitry, 42:79-84.
  • Jyani G, Prinja S, Ambekar A, Bahuguna P, Kumar R (2019). Health impact and economic burden of alcohol consumption in IndiaInternational Journal of Drug Policy, 69; 34-42
  • Kathiresan P, Ambekar A, Sarkar S. (2019). Opioid Substitution Treatment Using Buprenorphine for Management of Dependence on Natural Opioids: Case Series,Indian J Psychol Med 11;41(6):586-588
  • Sood A, Mishra A, Ambekar A (2019), Trends in alcohol consumption and expenditure: Analysis of household data from nationally representative sample from India,Asian Journal of Psychaitry, 22;40:116-123.
  • Saini R, Rao R, Parmar A, Mishra AK, Ambekar A, Agrawal A, Dhingra N. (2019), Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community-based study.Drug Alcohol Rev.. doi: 10.1111/dar.13016.
  • Jain R, Quraishi R, Verma A, Ambekar A. (2019). Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users.Indian J Pharmacol; 51(1):40-44.
  • Rao R, Varshney M, Singh S, Agrawal A, Ambekar A(2019), Mental Healthcare Act, 2017 and Addiction Treatment: Potential Pitfalls and Trepidations Indian J Psychiatry, 61(2); 208-212
  • Mandal P, Parmar A, Ambekar A, Dhawan A(2019), Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian Journal of Psychaitry22;41:17-19
  • Ambekar A, Rao R, Agrawal A, Kathiresan P (2019) Research on opioid substitution therapy in India: A brief, narrative review. Indian J Psychiatry; 60:265-70
  • Quraishi R, Varshney M, Singh A, Singh D, Kumar M, Rao R, Jain R, Ambekar A. (2019). Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study. Indian J Psychol Med. Nov 11;41(6):529-534.
  • Chattopadhyay A, Gupta S, Dayal P, Mandal P, Agrawal A, Ambekar A (2019). Butorphanol dependence in a health-care professional: A case report with narrative review. Journal of Substance Use, doi.org/10.1080/14659891.2019.1604839
  • Dandona R, Kumar GA, Dhaliwal RS, Naghavi M, Vos T, Shukla DK, Vijayakumar L, Gururaj G, Thakur JS, Ambekar A, Sagar R, Arora M, Bhardwaj D, Chakma JK, Dutta E, Furtado M, Glenn S, Hawley C, Johnson SC, Khanna T, Kutz M, Mountjoy-Venning WC, Muraleedharan P, Rangaswamy T, Varghese CM, Varghese M, Reddy KS, Murray CJL, Swaminathan S, Dandona L (2018). Gender differentials and state variations in suicide deaths in India: the Global Burden of Disease Study 1990-2016. Lancet Public Health.  Oct;3(10):e478-e489. doi: 10.1016/S2468-2667(18)30138-5.
  • Ambekar A, Mongia M, (2018). Planning research in psychosocial interventions. Indian Journal of Psychiatry; 60 (8): 575-582
  • Rumpf HJ, Achab S, Billieux J, Bowden-Jones H, Carragher N, Demetrovics Z, Higuchi S, King DL, Mann K, Potenza M, Saunders JB, Abbott M, Ambekar A, Aricak OT, Assanangkornchai S, Bahar N, Borges G, Brand M, Chan EM, Chung T, Derevensky J, Kashef AE, Farrell M, Fineberg NA, Gandin C, Gentile DA, Griffiths MD, Goudriaan AE, Grall-Bronnec M, Hao W, Hodgins DC, Ip P, Király O, Lee HK, Kuss D, Lemmens JS, Long J, Lopez-Fernandez O, Mihara S, Petry NM, Pontes HM, Rahimi-Movaghar A, Rehbein F, Rehm J, Scafato E, Sharma M, Spritzer D, Stein DJ, Tam P, Weinstein A, Wittchen HU, Wölfling K, Zullino D, Poznyak V (2018). Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective. J Behav Addict.:1-6. doi: 10.1556/2006.7.2018.59.
  • Sahni S, Tickoo M, Gupta R, Vaswani M, Ambekar A, Grover T, Sharma A. (2018). Association of serotonin and GABA pathway gene polymorphisms with alcohol dependence: A preliminary study. Asian J Psychiatry. pii: S1876-2018(17)30466-5. doi: 10.1016/j.ajp.2018.04.023
  • Ambekar A, Parmar A, Mandal P & Therthani S. (2017) High proportion of pentazocine dependence among treatment-seeking female injecting drug users (FIDUs) in India: A distinct population? Journal of Substance Use. DOI: 10.1080/14659891.2017.1364306
  • Dandona L. et al, (India State-level Disease Burden Initiative Collaborators). (2017) Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. LANCET, DOI: http://dx.doi.org/10.1016/S0140-6736(17)32804-0
  • Ambekar A, Murthy P, Basu D, Rao GP & Mohan A. (2017) Challenges in the scale-up of Opioid Substitution Treatment (OST) in India (Guest Editorial), Indian Journal of Psychiatry;59:6-9
  • Dhawan A,Rao R, Ambekar A, Pusp A & Ray R. (2017) Treatment of substance use disorders through the government health facilities: Developments in the Drug De-addiction Programme of Ministry of Health and Family Welfare, Government of India Indian Journal of Psychiatry. DOI:10.4103/psychiatry.IndianJPsychiatry_19_17 
  • Gupta S, Lal R, Rao R, Mishra A K & Ambekar A. (2017) Pattern of alcohol use among problem alcohol users in a community-based setting in India: A cross-sectional study. Journal of Substance Use. DOI: 10.1080/14659891.2017.1366557
  • Schaub MP, Tiburcio M, Martinez N, Ambekar A, Balhara YPS, Wenger A, Andrade ALM, Padruchny D, Osipchik S, Gehring E, Poznyak V, Rekve D & Souza-Formigoni MLO, WHO e-health project on Alcohol and Health Investigators Group (2017) Alcohol e-Help: Study protocol for a Web-based self-help program to reduce alcohol use in adults with drinking patterns considered harmful, hazardous, or suggestive of dependence in middle-income countries. Addiction. doi: 10.1111/add.14034
  • Saunders J B, Hao W, Long J, King DL, Mann K, Fauth-Bühler M, Rumpf HJ, Bowden-Jones H, Rahimi-Movaghar A, Chung T, Chan E, Bahar N, Achab S, Lee HK, Potenza M, Petry N, Spritzer D, Ambekar A, Derevensky J, Griffiths MD, Pontes HM, Kuss D, Higuchi S, Mihara S, Assangangkornchai S, Sharma M, Kashef A E, Ip P, Farrell M, Scafato E, Carragher N & Poznyak V. (2017) Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention J Behav Addict:1-9. doi: 10.1556/2006.6.2017.039
  • Singh R, Grover T, Gupta R, Ambekar A, Jain R and Sharma A. (2017) An Association Study of the COMT and GABA Gene Variants with Alcohol Dependence. J Addict Res Ther, 8:6 DOI: 10.4172/2155-6105.1000350
  • Gupta R, Grover T, Ambekar A, Singh R, Vaswani M and Sharma A. (2017) An Association Study on the Glutamate Pathway GRIN2A Gene Polymorphisms with Heroin Dependence. J Addict Res Ther, 8:6 DOI: 10.4172/2155-6105.1000348
  • Qureshi R, Jain R, Ambekar A & Mishra AK. (2017) Association of ankyrin repeats & kinase domain containing 1 (ANKK1) polymorphism with co-morbid alcohol and nicotine dependence: A pilot study from a tertiary care treatment center in North India. Indian Journal of Medical Research, (145); 33-38
  • Gupta SK, Ambekar A, Dhawan A & Mehta M (2017). Personality profile of alcohol and injecting opioid users: A comparative study from India, Asian Journal of Psychatry, 25: 142-146
  • Mandal P, Parmar A, Therthani S & Atul Ambekar (2016). Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment center, Journal of Substance Use, DOI: 10.1080/14659891.2016.1217092
  • Kuppili PP, Bhad R, Rao R, Dayal P & Ambekar A, (2016)The mis-adventurous use of prescription opioids in chronic non-cancer pain, National Medical Journal of India DOI: 10.3109/14659891.2015.1040092
  • Rao R, Ambekar A, Agrawal A, Pawar AK, Mishra AK & Khandelwal S. (2016) Evaluation of a five-day training programme on opioid substitution therapy in India, Drugs: Education, Prevention and Policy: DOI: 10.3109/09687637.2016.1167166
  • Rao R, Mandal P, Gupta R, Ramashankar P, Mishra AK, Ambekar A, Jhanjee S & Dhawan A. (2015) Factors affecting drug use during incarceration: a cross-sectional study of opioid-dependent persons from India, Journal of Substance Abuse Treatment: DOI:10.1016/j.jsat.2015.08.009
  • Bhad R, Dayal P, Kumar S & Ambekar A, (2015) The drug ketamine: a double edged sword for mental health professionals J Subst Use; DOI: 10.3109/14659891.2015.1040092
  • Varshney M, Ambekar A, Lal R, Yadav D, Rao R & Mishra AK, (2015) Brief Interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: A prospective study from India, Addictive Disorders and Their Treatment,: doi: 10.1097/ADT.0000000000000076
  • Ambekar A, Rao R, Agrawal A, Mishra AK, Kishore K, Mukherjee D & Albertin C, (2015) Pattern of drug use and associated behaviours among female injecting drug users from northeast India: a multi-centric, cross-sectional, comparative study, Substance Use and Misuse,: 50:10, 1332-1340; DOI: 10.3109/10826084.2015.101313
  • Prakash S, Ambekar A & Dayal P, (2015) Occasional alcohol use, relapse to opioids and the role of disulfiram, Journal of Substance Use,DOI: 10.3109 / 14659891. 2015. 1029024
  • Ramdurg S, Ambekar A & Lal R. (2015) Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. Ind Psychiatry J;24:29-34
  • Dhawan A, Chopra A, Ambekar A & Ray R. (2015) Treatment seeking behavior of inhalant using street children: Are we prepared to meet their treatment needs. Indian J Psychol Med;37:282-7
  • Ambekar A, Rao R, Mishra AK & Agrawal A, (2014) Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs, Drug Alcohol Rev 34: 97-104. doi: 10.1111/dar.12208
  • Gupta SK, Ambekar A, Dhawan A & Mehta M, (2014) Psychosocial factors associated with HIV-related high-risk injection behavior among people who inject drugs; 19 (2): 62-68
  • Bhad R, Ambekar A, and Dayal P, The lizard: an unconventional psychoactive substance?, Journal of Substance Use, Early Online: 1–2, DOI: 10.3109/14659891.2014.987836
  • Goyal S, Ambekar A & Ray R. Jul - Sep 2014 Ketamine Dependence in an Anesthesiologist: An Occupational Hazard? Indian Journal of Psychological Medicine,; Vol 36; 3
  • Pal A, Ambekar A & Bera SC, (2014) Pharmacovigilance in psychiatry: time to take notice Journal of Drug Discovery and Therapeutics, 2 (20), 38-39
  • Ambekar A, Rao R, Pun A, Kumar S & Kishore K (2013), The trajectory of Methadone Maintenance Treatment in Nepal, International Journal of Drug Policy 2013 Jul 8. doi:pii: S0955-3959(13)00094-7. 10.1016/j.drugpo.2013.06.001
  • Ambekar A, Rao R, Agrawal A (2013). India’s National Narcotic Drugs and Psychotropic Substances Policy 2012: A 20th Century Document in 21st Century. International Journal of Drug Policy 2013 Jul;24(4):374-5
  • Rao R, Agrawal A, Kishore K & Ambekar A (2013). Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning. Bulletin of the World Health Organisation, Volume 91, Number 2, February 2013
  • Prasad P, Ambekar A & Vaswani M,(2013) Case–control association analysis of Dopamine receptor polymorphisms in alcohol dependence: a pilot study in Indian males, BMC Research Notes, 6:418
  • Quraishi R, Jain R & Ambekar A (2013), The Use of Dried Blood Spot Samples in Screening Drugs of Abuse Pharmacology & Pharmacy,4 (2); 152
  • Ambekar A & Pawar A, (2012) Low Dead-Space Syringes for HIV prevention among people who inject drugs: Interesting, but a much stronger case is required. International Journal of Drug Policy. pii: S0955-3959(12)00149-1. doi: 10.1016/j.drugpo.2012.09.009.
  • Singh RR & Ambekar A, (2012) Opioid substitution treatment in a public health setting: A collaboration between hospitals and NGOs in the Punjab. International Journal of Drug Policy, 23; 169– 171
  • Rao R, Ambekar A, Yadav S, Sethi H & Dhawan A, (2011)Slow-release oral morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India Journal of Substance Use; Early Online:1–7
  • Larance B, Ambekar A, Azim T, Murthy P, Panda S, Degenhardt L & Mathers B,(2011) The availability, diversion and injection of pharmaceutical opioids in South Asia, Drug Alcohol Rev. May;30(3):246-54.
  • Ramdurg S, Ambekar A & Lal R.(2011) Sexual Dysfunction among Male Patients Receiving Buprenorphine and Naltrexone Maintenance Therapy for Opioid Dependence J Sex Med. Mar 2. doi: 10.1111
  • Sood M & Ambekar A,(2011) Giving ‘fresh fruit juice’ to patient as a metaphor for giving care by family members / care takers. National Medical Journal of India, 24 (6): 375
  • Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A & Strathdee SA, (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, LANCET, 375(9719)  1014-1028; DOI:10.1016/S0140-6736(10)60232-2
  • Prasad P, Ambekar A & Vaswani M, (2010) Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study, BMC Med Genet. 11;11:24  

Books And Monographs (authored / Edited): Training Manuals / Resource Materials

Books And Monographs (authored / Edited): Research reports

Chapters In Books / Monographs

  • Ambekar A, Singh S (2022). “Dealing with Drug Addiction”. In Chadda RK, Pratap S, Sood M, Deb KS (eds) Mental Health at Crossroads: Challenges and Solutions. New Delhi: White Falcon Publishing
  • Ambekar A (2021), “Challenges in managing substance use disorders during COVID19 pandemic”. In Bhattacharyya R, Dalui A, Bandhopadhyay T, Sen A (eds)Guidelines for managing mental health issues during COVID 19 pandemic. Kolkata: Indian Medical Association – Bengal State Branch
  • Ambekar A., Rao R., Agrawal A. (2021). “Contribution towards national policies and programs related to addiction treatment services during COVID-19 pandemic: An experiential account” (pp 70-74). In Chadda R, Sood M, Deep R (eds),COVID19 pandemic and Mental Health: Experiences of organizing services at a tertiary care healthcare institution. New Delhi: Dept. of Psychiatry and NDDTC, AIIMS, New Delhi
  • Ambekar A, George A (2020). “Integrating the biological basis and the pharmacotherapy of Alcohol dependence: Focus on current and potential interventions.” In Gupta N, Kumar P, Mohan A (eds)Recent Advances in Biological Psychiatry – Theme: Addiction Psychiatry (2nd ed). Mumbai: Indian Association of Biological Psychiatry
  • Ambekar A, Mandal P (2020). “Substance related disorders” In Singh PK, Singh OP, Kumar V (eds)IPS Text book of Undergraduate Psychiatry. New Delhi: Jaypee brothers medical publishers
  • Qureshi R, Ambekar A (2018). “Genetics of Alcohol Use Disorders” in Bhuyan D (Ed).Psychiatry Update. Dibrugarh: Assam Medical College
  • Ambekar A, Chawla N (2018). “Cannabis: From Neurobiology to Policy” in Bhuyan D (Ed).Psychiatry Update. Dibrugarh: Assam Medical College
  • Dabholkar H, Ambekar A & Benegal V,(2017) “Psychiatric Emergencies in Substance Abuse” in Thara R, Vijayakumar L (eds), Emergencies in Psychiatry in Low and Middle Income countries, Edition - II, New York: Routledge
  • Qureshi R, Jain R & Ambekar A. (2017) “Dried Blood Spots for Testing Drugs of Misuse”, in Wolff K (Ed),Detection of Drug Misuse : Biomarkers, Analytical Advances and Interpretation, Cambridge: Royal Society of Chemistry
  • Ambekar A & Goyal S (2016), “Clinical Practice Guidelines for treatment of Amphetamine Type Stimulants”, in Basu D, Dalal PK (eds),Clinical Practice Guidelines on Newer and Emerging Addictive Disorders in India, New Delhi: Indian Psychiatric Society
  • Srivastava P, Mehta M, Ambekar A & Sagar R (2015), “Depression” in Mehta M, Sagar R (eds),A Practical Approach to Cognitive Behaviour Therapy for Adolescents, New Delhi: Springer India
  • Ambekar A & Pawar A (2015), “Epidemiology of Substance Use in India: Emerging insights”. Hyderabad: Souvenir of Annual National Conference of Indian Psychiatric Society, 2015 (ANCIPS-2015).
  • Ambekar A & Goyal S (2015), “Clinical Practice Guidelines for treatment of Opioid Use Disorders”, in Basu D, Dalal PK (eds), Handbook -Clinical Practice Guidelines for Substance Use Disorders, New Delhi: Indian Psychiatric Society
  • Ambekar A (2014), “Management of Substance Use in India: Where we are and where do we need to go?”.Souvenir of Annual Conference of Indian Psychiatric Society – East Zone, 2014 (CEZIPS-2014), Dibrugarh:Department of Psychiatry, Assam Medical College
  • Ambekar A & Deb KS , (2013). “Import of Narcotics for Clinical Trial Supplies”, in Kshirsagar N, Kulkarni T, Desai A, Shah J (eds), Emergencies in Psychiatry in Low and Middle Income countries , New Delhi: Indian Council of Medical Research (ICMR)
  • Ambekar A (2013), “Pharmacotherapy for opioid dependence”, in Rakesh Lal, Ramandeep Pattnayak (eds), Substance Use Disorders: Handbook for Physicians. New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
  • Ambekar A & Goyal S (2013), “Methadone Maintenance Treatment” in Dhawan A, Jhanjhi S (eds) Manual for Long-term pharmacotherapy of alcohol and opiate dependence New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
  • Ambekar A & Kattimani S (2013), Anti-craving medications for long-term treatment of alcohol dependence, in Dhawan A, Jhanjhi S (eds) Manual for Long-term pharmacotherapy of alcohol and opiate dependence . New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
  • Dabholkar H, Ambekar A & Benegal V, “Psychiatric Emergencies in Substance Abuse” in Thara R, Vijayakumar L (eds), Emergencies in Psychiatry in Low and Middle Income countries , (2012), Manipal: Byword Books
Default Woman Doctor Image

Prof.
Sonali Jhanjee

Female

MD, DNB(Psychiatry)

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
sonalijhanjee@gmail.com

General OPD

Friday

Special Clinic

Monday (Tobacco Cessation Clinic, NDDTC)
Wednesday (Ward Rounds)
Thursday (Patient education facility)

Field of Interest

Interventional (both pharmacological and psychosocial) research in tobacco cessation, Teaching/Training/Capacity building for treatment of nicotine dependence and substance abuse treatment,Yoga and meditation in stress reduction and treatment of drug abuse, Opioid substitution treatment, community based treatment of drug use

Total number of publications till date : 65

Significant events

  • Part of the SRNT Global Curriculum Review Board
  • Resource person for WHO-ERS “Train the trainer” tobacco cessation  workshop in Dhaka, Bangladesh on 8th-9th January,2017
  • Part of an Roundtable discussion in 2014 held under National Tobacco Control Programme to discuss the current evidence around the existing and potential impact Of Electronic Nicotine Delivery Systems (ENDS) on public health and discuss regulation of e-cigarettes under existing legislative framework
  • Expert Groups
  • Finalizing course modules on “Tobacco Quit Line Services” under MOH&FW,2016
  • Finalizing modules of the project “mHealth for Tobacco Cessation” under MOH&FW, 2015
  • Meeting dealing with  ‘Development of Training module / Strategy’ under NTCP, MOH&FW
  • Part of ICMR task force on proposal for ICMR-funded task force project on epidemiology of substance abuse in the state of Punjab (esasp)(2013-14)
  • Part of an expert team convened by UNODC (United Nations Office of Drugs and Crime, Regional Office for South Asia, New Delhi)  to evaluate oral substitution(with buprenorphine) sites in India in 2007.
  • As desired by Standing Parliamentary committee on demand for grants, was part of AIIMS team to carry out site visits to Ministry Of Health funded drug deaddiction centres for evaluation of number of cases in treatment and outcome following treatment in 2008.

8 Presentations made at scientific meetings/ conferences/ workshops 50

Investigator in funded projects along with year completed

1.Rolling out of Opioid Substitution Treatment (OST) in Tihar prisons, India-A collaborative project of AIIMS,UNODC-ROSA & TIHAR PRISONS.(PI) Funded by UNODC ROSA)(2008-12)

2.Community based brief intervention vs simple advice for women tobacco users.(PI) Funded by ICMR 2013-14

Investigator in non-funded projects along with year and completed

  • Demographic, clinical characteristics and treatment outcome of opioid drug users on OST with buprenorphine in a community mobile clinic (2011-14)
  • Tobacco use in opioid dependent patients on maintenance treatment.(2014-15)
  • A retrospective chart review of tobacco use parameters and  outcome of tobacco cessation treatment in polydrug users (2010-12)

Investigator in funded projects along with year and title ongoing

Investigator in non-funded projects along with year and title ongoing

  • Patterns of use and psychosocial consequences of cannabis use in a community setting(2015-ongoing)
  • Risk behaviors of young Injection drug users (IDU) in community setting(ongoing)

Co-investigator in funded projects along with year and title completed

  • 1. Efficacy of Varenicline for smokeless tobacco use.Funded by  National Institute of Health(NIH), U.S.A  2011- 13
  • 2.Cognitive Behavioural based Intervention in Group Setting for Tobacco Cessation in tertiary de-addiction center in Northern India. Funded by ICMR,2015-2016
  • 3.Impact of a package of intensive smoking-cessation interventions versus basic smoking-cessation advice on outcomes in smear-positive patients with pulmonary tuberculosis. Funded by  EU FP7 Programme & ICMR (2009- 16)
  • 4. Oral substitution with buprenorphine Co-I Funded by UNODC- ROSA(2007-2008)
  • 5. Developing a network of De-addiction services from the government, NGO and private sector. (funded by WHO,2011)

Co- investigator in non-funded projects along with year and completed

  • A study of experience related to crime and imprisonment among service recipients in community drug treatment clinic(2013-15)
  • Comparison of Self-Report of Tobacco Use And Urinary Cotinine Levels Among Drug Dependents: A Pilot Study.(2009-10)

Co- investigator in funded projects along with year  and title ongoing

Co- investigator in non-funded projects along with year and title ongoing

  • Effect of smoking on Platelets Monoamine Oxidase B activity levels  in Opioid Dependent  Patients on maintenance treatment: An exploratory study (2016-till date)

Thesis supervised for MD/ PhD/DM

  • - as guide (number only)  4
  • -as co-guide (number only) 10

Details of publications since 2004 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Journals

  • Jhanjee S, Lal R, Mishra A, Yadav D. A Randomized Pilot Study of Brief Intervention versus Simple Advice for Women Tobacco Users in an Urban Community in India. Indian Journal of Psychological Medicine(Accepted for publication).
  • Jhanjee S. Putting tobacco harm reduction in perspective: is it a viable alternative? Indian Journal of Medical Research. 2016; 143(1): 25-9
  • Rao R, Mandal P, Gupta R, Ramshankar P, Mishra A, Ambekar A, Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. Journal of substance abuse treatment. 2016; 61:13-7
  • Jhanjee S. Sethi H. Characteristics of opioid drug users in an urban community clinic. Indian Journal of Social Psychiatry. 2016;32(2): 154-57
  • Jhanjee S, SuruchiP ,Girdhar N,  Gunasekhar R, Jain R,  Sethi H, Sarangi J. Opioid Substitution Treatment in Tihar prisons, India: Process of implementation. International Journal on Drug Policy 2015; 26: 890–891
  • Jhanjee S, Lal R, Mishra A, Yadav D. Tobacco use and dental myths In India: need for specific intervention Gerodontology 2015; doi: 10.1111/ger.12200
  • Jhanjee S, Jain R, Jain V, Gupta T, Mittal S, Goelz P, Schnoll RA. Evaluating the effects of varenicline on craving, withdrawal and affect in a randomized double-blind placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India. Journal of Psychoactive Drugs. 2015 ;47(4):331-5.
  • Jain R, Jhanjee S, Jain V, Gupta T, Mittal S, Chauhan, P, Raghav R, Goelz P, Schnoll RA. Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from A Clinical Trial of Varenicline in India Journal of Psychoactive Drugs 2015;47(4):331-5.
  • Jhanjee S. Sethi H. Characteristics of opioid drug users in an urban community clinic. Indian Journal of Social Psychiatry. 2016;32(2): 154-57
  • Jhanjee S. Dyslexia and Substance abuse: the under-recognized link. Indian Journal of Psychological Medicine. 2015;37 3 374-5
  • Piyali M, Jain R, Jhanjee S, Sreenivas V. Psychological barriers to tobacco cessation in Indian buprenorphine-naloxone maintained patients -A pilot study. Indian Journal of Psychological Medicine. 2015; 37(3):299-304
  • Sethi H, Jhanjee S. Use of Alcohol among treatment seeking illicit drug users in India. Journal of Mental Health and Human Behaviour 19(1): 2014: 19(1). 29-31
  • Jhanjee S. Evidence Based Psychosocial Interventions in Substance Use. Indian Journal of Psychological Medicine. 2014;36:112-8
  • Jain R, Jhanjee S, Jain V, Gupta T, Mittal S, Goelz P, Wileyto EP, Schnoll RA (2014). A Double-Blind Placebo-Controlled Randomized Trial of Varenicline for Smokeless Tobacco Dependence in India. Nicotine and Tobacco Research.16(1):50-7.
  • Jhanjee S, Kumar R (2013). Mobile clinic services for opioid users: a feasible treatment modality. Asian Journal of Psychiatry 6(6):626.
  • Jhanjee S (2012). Providing Drug abuse Treatment in prison: A call for action. Asian Journal of Psychiatry 5 : 114-115
  • Arora S, Gupta S, Jhanjee S (2012): A descriptive study to assess dysthymia and select variables associated with tobacco use among adolescents. Indian Journal of Psychiatric Nursing Volume 3(1): 13-15
  • Jain R, Balhara Y P, Jhanjee S &Sethi HM(2012): Concordance Between Urinary Cotinine Levels and Self-Reported Tobacco Use Among Drug-Dependent Persons: A Pilot Study, Substance Abuse, 33:2, 99-102
  • Goyal S, Jhanjee S (2011): Opioid use in prison population and its relationship to crime: A review . Journal of Mental Health and Human Behaviour, 16(2).
  • Jhanjee S. Sethi H (2011): Tobacco use in drug dependent patients- an even greater dilemma. Indian journal of Medical Specialities, 2(2):165-166
  • Jhanjee S, Lal T, Mondal A, Jain K (2011):  Heroin dependent family: A biopsychosocial context. Substance Abuse, 32:157–158
  • Jhanjee S (2011):   Tobacco control in India- Where are we now? Delhi Psychiatry journal. 14(1), 26-32.
  • Jhanjee S, Sethi H (2010): The Fagerström Test For Nicotine Dependence in An Indian Sample of Daily smokers With Poly Drug Use. Nicotine and  Tobacco  Research.12(11):1162-6.
  • Jhanjee S, Prakash B (2010):BuprenorphineMaintainence in pregnancy. Asian Journal of Psychiatry. 3(3), 157
  • Basu A, Jhanjee S (2010). Review of current pharmacotherapy for nicotine dependence. Delhi Psychiatry journal 13(2): 240-246
  • Jhanjee S, Balhara Y P, Sethi H (2009) Tobacco use among drug dependent patients in treatment setting Delhi Psychiatry journal. 12(2), 247-251.
  • Jhanjee S (2007) Substance use among women: Indian Scenario.In Drug Abuse: News-n-Views; 3-5
  • Varghese S. Sagar R, Jhanjee S. (2006) Chronic renal failure and Electroconvulsive Therapy Indian Journal of Medical Science 60 : 114-115
  • Jhanjee S, Goyal P, Kattimani S. (2006) Recent pharmacological Term treatment of Alcohol dependence: a review. Delhi Psychiatry Bulletin Vol.9 No.2 pg 111-118

Principal author

  • Principal Author: Scientific report- Rolling out OST in Tihar prisons India(2013)
  • Principal Author:  Monograph Scientific. Community based brief Intervention vs simple advice for women tobacco users.

Book Co-editor

  • Dhawan A, JhanjeeS(eds)(Revised 2013). Manual for long term pharmacotherapy. Sponsored by WHO (India) and Ministry of Health and Family Welfare, Government of India
  • Kochupillai V, Dhawan A, Jhanjee S, Pattanayak R (eds). Book of Abstracts. Conference on Stress reduction skills. Scientific update, 30th and 31st august, 2014

Chapter in Books

  • Jhanjee S (2015). Behavioural and Psychological Approaches for Cessation. In Tobacco cessation for primary care providers in India. Public Health Foundation of India (under publication)
  • Jhanjee S (2013). Nicotine dependence. In Lal R, PattanayakR(eds). Substance use disorders: Handbook for physicians, NDDTC, AIIMS. pp 88-97.
  • Jhanjee S, Mohan I (2007) Long term use of naltrexone for opiate dependence. In Dhawan A, Jhanjee  S(eds)   Manual for long term pharmacotherapy pp.38-50.
  • Jhanjee S,  Agrawal A (2005) Opioid intoxication and management of withdrawal state. In Hemraj Pal (ed) Case Book on Substance Use Disorder –Manual for Physicians, pp.41-44

Abstracts published

  • Jhanjee S, Bhad R,  Sethi H, Rao R. Tobacco use in Opioid Dependent Patients on Buprenorphine Maintenance Treatment. Indian Journal of Psychiatry. 2016; 58(Suppl): S48-49
  • Jhanjee S, Lal R, Mishra A, Yadav D. Tobacco use characteristics amongst women in an urban community.Indian Journal of Psychiatry. 2015 Jan; 57(Suppl 1): S11–S112.
  • Jhanjee S, SuruchiP ,Girdhar N,  Gunasekhar R, Jain R,  Sethi H. In-prison outcomes of Buprenorphine maintenance for prisoners: results from a pilot intervention in Tihar prisons, India. Alcohol and Alcoholism 2014 vol 49, supp1 i64
  • Mandal P, Jain R, Jhanjee S,  Sreenivas V. Barriers of tobacco cessation among Indian Buprenorphine- naloxone maintained patients. Alcohol and Alcoholism  2014 vol 49, supp1i6
  • Jhanjee S, Lal R, Mishra A, Yadav D. Tobacco use characteristics amongst women in an urban Community. Indian J Psychiatry 2015 57 (Supplement) S60-61
  • Jhanjee S, Mandal P, Singh D. Tobacco use in opioid dependent patients maintained on Buprenorphine naloxone treatment. Indian Journal of Psychiatry. 2014; 56 Suppl, S55
  • Jhanjee S. Prevalence and correlates of tobacco use among youth: In Symposium “Opportunities and challenges for youth Tobacco cessation” Indian Journal of Social Psychiatry,  2014, 30 (3-4):  A10
  • Jhanjee S. Putting tobacco harm reduction in perspective: Is  there any evidence?: SonaliJhanjee Indian Journal of Social Psychiatry, 2013, 29 (3-4), A9-A16
  • Jhanjee S. Efficacy of psychosocial  interventions in substance  use. Indian Journal of Social Psychiatry.2012; 28(3-4),  A-19
  • Jhanjee S, Sethi H. Differential characteristics of injectable drug users in community setting. Indian Journal of Psychiatry. 2011;53:S 38
  • Jhanjee S, Sethi H. Oral substitution with buprenorphine in a community mobile clinic for opioid dependent patients. Indian Journal of Psychiatry. 2010; 52: S 19
  • Jhanjee S, Balhara Y.P, Sethi H. Tobacco use pattern and severity of dependence in drug dependent patients. Relation of Opioid use and the use of Tobacco products Indian Journal of Psychiatry. 2009;51: S135
  • Jhanjee S, Sethi H. Demographic and clinical characteristics of Opiod Drug Users In A Community Mobile Clinic Canadian Journal of Addiction Medicine. 2009;1(1):P 23
  • Balhara Y.P, Jhanjee S, Majumdar P. Relation of Opioid use and the use of Tobacco products Indian Journal of Psychiatry.2008; 50 Suppl, P14
  • Balhara Y.P, Jhanjee S, VermaR : Factors associated with Initiation, Maintenance and Decision to quit in Tobacco Indian Journal of Psychiatry. 2008; 50 Suppl, P14
  • Jhanjee S , Goyal P, Chopra A(2007); One year profile of patients attending tobacco cessation clinic in a National level de-addiction center. Indian Journal of Psychiatry. 2007; 49 Suppl, P27
  • Kushwaha V, Verma R, Jhanjee S, Ambekar A. Amphetamine type stimulants: Forewarned is forearmed  Indian Journal of Psychiatry. 2007; 49 Suppl, P27
Prof. Anju Dhawan

Prof.
Anju Dhawan

Female

MBBS, MD Psychiatry

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
dranjudhawan@gmail.com

General OPD

Monday

Special Clinic

Wednesday (Administrative rounds)
Thursday (Adolescent Clinic)
Friday (Ward Rounds)

Awards and Honors

National

  • Member of the Working Group on Drug Abuse and Addiction among children constituted by NCPCR (2012)
  • Awarded membership of the Technical Resource Group of the Adolescent Health Division, MOHFW for contribution to public health strategy for adolescent health (2015-16)

International

  • Awarded Fogarty International Training and Research Fellowship for HIV AIDS- UCLA (2004)
  • Member WHO Expert Committee on Development of Treatment Guidelines for Management of Drug Use in Pregnant Women (2013)
  • Contributed as an expert to the expert and authors meeting organized by Colombo Plan and US Department of State to the Development of Training Curricula for Service Providers to Address Child Drug Addiction on held at Washington DC for development of a module for children 2014-15(22 –24 October, 2014)
  • Awarded Membership of the International Society of Addiction Medicine Education and Training Committee (2015-22)
  • Member WHO Expert Committee on Drug Use and TB

Investigator/ Co-investigator in funded projects along with year completed/ongoing

Projects as Chief InvestigatorSource of fundingYear
Psychotropic substance abuseUnited Nations Drug Control Programme, Regional Office for South Asia (UNDCP ROSA)2001-02
Evaluation of functioning of de-addiction centres in the countryWHO (India)2001-2002
Opioid Substitution Treatment with BuprenorphineUnited Nations Office on Drugs and Crime, Regional Office for South Asia (UNODC-ROSA)2006-2009
Assessment of feasibility and effectiveness of Methadone Maintenance Treatment in IndiaUNODC (ROSA)2011-2013
Effectiveness of Yoga in patients of Opioid DependenceCentral Council for Research in Yoga and Naturopathy, AYUSH, Ministry of Health and Family Welfare2009-2011
Assessment of pattern, profile and correlates of substance use in childrenNCPCR2012-2013
Training of doctors on Substance Use DisordersDepartment of Revenue, Ministry of Finance2010-15
Mapping and Size Estimation of Street Children Who Use Drugs in DelhiDepartment of Women and Child development, Delhi Govt2015-16
Extent of Mental Health issues & Addictive Behavior among Adolescents seeking help in Adolescent Friendly Health Clinics in DelhiAdolescent Health Division, Directorate of Family Welfare, Govt of NCT of Delhi2019-2020
Survey on Substance use among School and College StudentsMinistry of Social Justice and Empowerment, Government of India2019-20
Screening and Intervention for Drug/Substance Use among Secondary School going ChildrenUEE Mission, Education Department Delhi2020-21
A prospective double blind, randomized clinical study to evaluate the antibody response after Covid-19 vaccine when provided along with KabasuraKudineer, a siddha medicineSSIAR2021-22
A prospective double blind, randomized clinical study to evaluate the antibody response after Covid-19 vaccine when provided along with NOQ19, an Ayurvedic medicineSSIAR2022

Research Projects as co-investigator-

Projects as Co-InvestigatorSource of fundingYear
Rapid Assessment Survey Project on Alcohol, Tobacco and other substances in Districts of Darjeeling, Kohima, AizwalWHO (India)1999
Rapid Assessment Survey Project on Alcohol, Tobacco and other substances in Districts of North Goa, Jodhpur, MadrasWHO (India)2000
Buprenorphine maintenance programme in Kohima districtWHO (India)2000
Global study on illegal drug marketsUNDCP and UNICRI2000-2001
A survey of prevalence of drug dependence and comorbidity in the general population of ThrissurWHO (India)2001-2002
Advance Statistical Analysis of National Survey Data using new methodologies without the addition of dataWHO (India)2001-2002
To undertake a study to examine the relationship of tobacco as a gateway drug and to determine the prevalence of substance use behavioural disorders including tobacco in Metropolis DelhiWHO (India)2002-2003
Database on Drug Abuse and HIV/AIDSUNODC (ROSA)2005-2009
Assessment of drug use in out of School AdolescentsWHO (India) 2008 
Development of intervention for drug use in out of school adolescents  WHO (India) 2008-2009
Coordination & convergence of Delhi District Health Services programmes & drug use intervention for the out of school childrenWHO (India)2010-2011
Developing a network of de-addiction services from the Government, NGO & Private sectorWHO (India)2010-2011
Extent of internet use amongst adolescents with non-psychotic disorders: A case control studyAIIMS2016
Validation of Teen Addiction Severity IndexAIIMS2016
Screening and Intervention for Drug/Substance Use among Elementary School going ChildrenUEE Mission, Education Department Delhi2020-21
A study to examine dependence, harm perception and motivation to quit amongst Indian areca nut users and pilot test an intervention moduleWHO (India)2020-22
Real World Effectiveness of add-on Yoga for patients with opioid dependence stabilized on treatmentDST SATYAM2022-23
A study to examine psych-social and behavioral domains among school going adolescents during covid-19 pandemic: Mixed study designICMR2022-24

Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing Substance use among adolescents seeking treatment at NDDTC (2014-15)

Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence (2018-19) 

Retrospective study to analyze the profile, the pattern of substance

use and outcome of treatment of adolescent patients who sought

treatment for opioid use (on-going)

To assess the effect of intervention of yoga and meditation-based structured programme for youth on the psychological functioning of medical students (on-going)

Thesis supervised for MD/ DM/PhD

- as guide (number only)- 8 

-as co-guide (number only)-PhD thesis-8, MD and DM thesis-16

Total number of publications till date- 144

Details of publications since 2010 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Articles

  • Ray Rajat, Dhawan A (2010). Drug Scheduling-Science and Cultural Perspective. Addiction, 105, 1150-55.
  • Balhara YPS, Jain R, Dhawan A, Mehta M (2010). Assessment of Abuse Liability of Pheniramine among Opioid Dependent Human Subjects. Journal of Substance Use, Posted online on December 7, 2010. (doi:10.3109/14659891.2010.513753).
  • Jain Kushal, Jain R, Dhawan A (2011). Double-Blind, Double-Dummy Randomized Controlled Study of Memantine versus Buprenorphine in Naloxone Precipitated Acute Withdrawal in Heroin Addicts. Journal of Opioid Management 7(1), 11-20.
  • Yadav D, Dhawan A, Balhara YPS, Yadav S (2010). Occupational Rehabilitation of Opiate Users on Maintenance Treatment. Journal of Social Work Practice in the Addictions, 10 (4), 413 – 422.
  • Ray Rajat, Dhawan A (2011). Diagnostic Orphans. Addiction, 106(5), 891-892.
  • Verma R, Balhara YPS, Dhawan A (2011). Inhalant abuse: An exploratory Study. Ind Psychiatry J, 20(2): 103-106.
  • Gupta T, Shah N, Mathur VP, Dhawan A (2012). Oral health status of a group of illicit drug users in Delhi, India. Community Dent Health, 29(1): 49-54.
  • Rao RV, Ambekar A, Yadav S, Sethi H, Dhawan A (2012). Slow release oral morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India. Journal of Substance Use, 17(3), 294-300.
  • Jyotsna VP, Joshi A, Ambekar S, Kumar N, Dhawan A, Sreenivas V (2012). Comprehensive yogic breathing program improves quality of life in patients with diabetes. Indian J Endocrinol Metab, 16(3): 423-8.
  • Dhawan A, Chopra A (2013). Does buprenorphine maintenance improve the quality of life of opioid users? Indian J Med Res, 137: 130-135.
  • Ray R, Dhawan A, Chopra A (2013). Addiction Research Centres and the Nurturing of Creativity, National Drug Dependence Treatment Centre - A profile. Addiction, 108(10):1705-10.
  • Quraishi R,  PattanayakJain R,  Dhawan A (2013). A descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care center in India. Indian J Psychol Med Apr, 35(2):174-9.
  • Gupta A, Mandal P, Bhargava R, Pattanayak RD, Sagar R, Dhawan A (2014). Marked exacerbation of ADHD after onset of inhalant use: a case report. J Neuropsychiatry Clin Neurosci, 26(4):E6-7.
  • Gupta K, Ambekar A, Dhawan A, Mehta M (2014) Psychosocial Factors Associated with HIV‑Related High‑risk Injection Behavior among People Who Inject Drugs. Journal of Mental Health and Human Behaviour, 19(2): 62-68.
  • Balhara YP, Ranjan R, Dhawan A, Yadav D (2014).Experiences from a community based substance use treatment centre in an urban resettlement colony in India. J Addict, 98:20-28.
  • Ranjan R, Pattanayak RD, Dhawan A (2014). Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases. Indian J Psychol Med, 36(4):439-43.
  • Jyotsna VP, Dhawan A, Sreenivas V, Deepak KK, Singla R (2014). Completion report: Effect of Comprehensive Yogic Breathing program on type 2 diabetes: A randomized control trial. Indian J EndocrinolMetab, 18(4):582-4.
  • Ranjan R, Kumar S, Pattanayak RD, Dhawan A, Sagar R (2014). (De-) criminalization of attempted suicide in India: A review. Ind Psychiatry J, 23(1):4-9.
  • Bhad R, Jain R, Dhawan A, Mehta M (2014). Biochemical Assessment of Inhalant Use among Adolescents: A Pilot Study from Tertiary De-Addiction Center of India. J Subst Abuse Alcohol, 2(3): 1021-1024.
  • Dhawan A, Chatterjee B, Balhara YPS, Bhargava R (2015). Issues in Child and adolescent substance use. Indian Journal of Psychiatry, 57(5): S186.
  • Ambekar A, Dhawan A, Lenin Singh RK, Rao R (2015). How to deliver Methadone Maintenance Treatment (MMT) for Opioid Dependence. Indian Journal of Psychiatry 57(5): S180.
  • Dhawan A, Chopra A, Ambekar A, Ray R (2015). Treatment Seeking Behavior of Inhalant Using Street Children: Are We Prepared to Meet Their Treatment Needs. Indian J Psychol Med, 37(3): 282-287.
  • Dhawan A, Chopra A, Jain R, Yadav D, Vedamurthachar (2015). Effectiveness of yogic breathing intervention on quality of life of opioid dependent users. Int J Yoga, 8(2): 144-147.
  • Rao R, Mandal P, Gupta R, Ramshankar P, Mishra A, Ambekar A, Jhanjee S, Dhawan A (2016). Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat, 61: 13-17.
  • Dhawan A, Chopra A, Ray R (2016). Preference for Treatment Setting by Substance Users in India. Indian J Psychol Med, 38(1): 42-45.
  • Bhad R, Jain R, Dhawan A, Mehta M (2016). Why do young people sniff? An exploratory study of adolescent inhalant abuse from north India. Journal of Substance Use, Published online 24 Mar 2016.
  • Bhad R, Jain R, Dhawan A, Mehta M (2016). A Clinic Based Study in Treatment Seeking Adolescent Inhalant Users in India: Implications for Management. Journal of Child and Adolescent Substance Abuse, Published online 22 Sept 2016, DOI: 10.1080/1067828X.2016.1222977
  • Dhawan A, Pattanayak R , Chopra A, Tikoo VK, Kumar R (2016) Injection drug use among children and adolescents in India: Ringing the alarm bells. Ind J Psy, 58:387-93.
  • Gupta P, Mandal P, Singh D,Pattanyak R,  Bhargava R, Dhawan A (2016). Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med Med , 38(5): 486–488.doi:  10.4103/0253-7176.191390
  • Das M M,  Jain R,  Dhawan A,  Kaur A (2016). Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial. J Opioid Manag, 12(6):421-430.
  • Gupta K, Dhawan A, Ambekar A, Mehta M (2016) High- Risk Sexual Behaviors in Young Men Seeking Treatment for Alcohol Dependence: A Qualitative Study. Journal of Psychosocial Research, 11(1): 103-114.
  • Gupta K, Ambekar A, Dhawan A, Mehta M (2017) Personality profile of alcohol and injecting opioid users: A comparative study from India. Asian Journal of Psychiatry, 25: 142–146.
  • Dhawan A, Pattanayak RD, Chopra A, Tikoo VK, Kumar R (2017) Pattern and profile of children using substances in India: Insights and recommendations. Natl Med J India, 30(4): 224-229.
  • Jain S, Dhawan A, Kumaran SS, Pattanayak RD, Jain R (2017) Cue-induced craving among inhalant users: Development and preliminary validation of a visual cue paradigm. Asian J Psychiatr 30: 202-207.
  • Dhawan A, Rao R, Ambekar A, Pusp A, Ray R (2017) Treatment of substance use disorders through the government health facilities: Developments in the "Drug De-addiction Programme" of Ministry of Health and Family Welfare, Government of India. Indian J Psychiatry 59(3): 380-384.
  • Dhawan A, Mandal P (2017) Preventive Strategies for Substance Use. Indian Journal of Social Psychiatry 33 (2): 108-111.
  • Singh G, Kaloiya GS, Dhawan A, Balhara YPS, Mishra AK (2018) Need for evaluation of underlying dysfunctional cognition in problem drinkers. Asian Journal of Psychiatry 31: 71-72.
  • Mandal P, Dhawan A (2018) Interventions in individuals with specific needs. Indian J Psychiatry 60(8): 553-558.
  • Raghav R, Jain R, Dhawan A, Ray TS, Kumar P (2018). Chronic co-administration of nalbuphine attenuates the development of opioid dependence. Pharmacology Biochemistry and Behavior 175: 130-138.
  • Dhawan A, Modak T, Sarkar S (2019). Transdermal  buprenorphine  patch :  Potential  for  role  in  management  of  opioid dependence. Asian J Psychiatr   40:88-91.
  • Mandal P, Parmar A, Ambekar A, Dhawan A (2019). Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr
  • Chawla N, Mandal P, Chatterjee B, Dhawan A (2019). Tramadol-associated pica. Psychiatry ClinNeurosci. 2019;73(1):43.
  • Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S (2019). Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine. Journal of Addiction Medicine doi: 10.1097/ADM.0000000000000539
  • Tripathi, R., Rao, R., Dhawan, A., Jain, R., &Sinha, S. (2020). Opioids and sleep–a review of literature. Sleep medicine67, 269-275.
  • Kethawath, S. M., Jain, R., Dhawan, A., &Sarkar, S. (2020). A review of peripheral brain-derived neurotrophic factor levels in alcohol-dependent patients: Current understanding. Indian journal of psychiatry62(1), 15.
  • Dhawan, A., Mishra, A. K., Ambekar, A., Chatterjee, B., Agrawal, A., &Bhargava, R. (2020). Estimating the size of substance using street children in Delhi using respondent-driven sampling (rds). Asian journal of psychiatry48, 101890.
  • Gupta, S., Bhatia, G., Sarkar, S., Chatterjee, B., Balhara, Y. P. S., &Dhawan, A. (2020). Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence: An exploratory study. Indian Journal of Psychiatry62(5), 501.
  • Kethawath, S. M., Jain, R., Dhawan, A., &Sarkar, S. (2020). Trajectory of liver function tests during the initial alcohol detoxification period: A preliminary analysis. Indian journal of psychiatry62(2), 225.
  • Jain, S., Dhawan, A., Kumaran, S. S., Deep, R., & Jain, R. (2020). BOLD activation during cue induced craving in adolescent inhalant users. Asian Journal of Psychiatry52, 102097.
  • Kethawath, S. M., Jain, R., Dhawan, A., Sarkar, S., & Kumar, M. (2020). An Observational Study of Serum Brain Derived Neurotrophic Factor Levels in Patients with Alcohol Dependence during Withdrawal. Journal of Psychoactive Drugs52(5), 440-446.
  • Verma, V., Mishra, A. K., Dhawan, A., &Nath, D. C. (2020). Diversity in substance use behaviour among street children of Delhi under Bayesian paradigm. BMC Medical Research Methodology20(1), 1-9.
  • Rao R, Dhawan A, Parmar A, Yadav D, Bhad R. (2021) Improving treatment of substance use disorders through community drug treatment clinics: An experiential account. IJCM.
  • Raghav, R., Jain, R., Jacob, T. G., Dhawan, A., & Roy, T. S. (2021). Co-administration of nalbuphine attenuates the morphine-induced anxiety and dopaminergic alterations in morphine-withdrawn rats. Psychopharmacology238(4), 1193-1211.
  • Batra P, Dhawan A, Pandey RM, Mehta M, Sagar R, Chopra A (2021). Substance use and its associated factors among school students. National medical journal of India, 1;34(2).
  • Singh, S., & Dhawan, A. (2021). Problematic substance and internet use among medical students. Indian Journal of Social Psychiatry37(2), 172.
  • Gupta, S., Jhanjee, S., & Dhawan, A. (2021). Effectiveness of Interventions Based on Yogic Breathing Practices (IB-YBP) on Substance Use Disorders—A Systematic Review of the Randomized Control Trials and Quasi-Experimental Trials. Substance Use & Misuse56(11), 1624-1641.
  • Singh, V. V., Dhawan, A., Chadda, R. K., Mishra, A. K., & Sarkar, S. (2022). A Prospective Three-Months Naturalistic Follow-Up Study of Outcomes of Patients with Opioid Dependence Discharged on Buprenorphine or Oral Naltrexone. Indian Journal of Psychological Medicine, 02537176211066739.
  • Sharma, R., Dhawan, A., Kaminer, Y., & Chopra, A. (2022). Teen Addiction Severity Index (T-ASI): Hindi Translation and Validation for Use in India. Indian Journal of Psychological Medicine, 02537176221090467.
  • Gupta, S., Dhawan, A. (2022). Methodological issues in conducting yoga- and meditation-based research: A narrative review and research implications. Journal of Ayurveda and integrative medicine13(3), 100620. https://doi.org/10.1016/j.jaim.2022.100620
  • Singh, V. V., Sarkar, S., Chadda, R. K., Mishra, A. K., & Dhawan, A. (2022). Reasons for leaving treatment among patients with opioid dependence: A 3-month prospective follow-up study. Journal of opioid management18(5), 455–466. https://doi.org/10.5055/jom.2022.0739

Abstracts

  • Pawar A., Dhawan A., Kr A., Varshney M. Profile of patients presenting to the child and adolescent substance use clinic at a tertiary care de-addiction center. .Indian J Psychiatry. 2013; 55(5:) 42-43.
  • Kr A, Pawar A, Dhawan A. Profile of substance using women presenting to a tertiary care de-addiction facility. Indian J Psychiatry. 2013; 55(5): 79.
  • Dhawan A, Chopra A, Balhara YPS. Building National Capacity For Management Of Substance Use Disorders. Alcohol and Alcoholism. 2014; 49 (suppl 1): i12 DOI: http://dx.doi.org/10.1093/alcalc/agu052.51

Chapter in Books

  • Ray Rajat, Dhawan A (2011) Substance Dependence: National policies and priorities. In Kulhara P, Avasthi A, Thirunavukarasu M, Grover S, Chankrabarti S (eds) Themes and issues in Contemporary Indian Psychiatry, Publication Committee, Indian Psychiatric Society, pg 70-101.
  • Dhawan A, PattanayakRamandeep (2011) Community based addiction psychiatry. In Chavan BS (ed) Textbook of Community Psychiatry.
  • Dhawan A, Deb KaushikSinha (2011). Situation update on the extent, pattern of drug abuse in street children. In A Trainers Manual on Drug Use Prevention, Treatment and Care for Street Children, Published by UNODC (ROSA).
  • Dhawan A, Prashanth R (2011). Brief orientation to medical management of drug abuse among street children. In A Trainers Manual on Drug Use Prevention, Treatment and Care for Street Children, Published by UNODC (ROSA).
  • Pattnayak R, Dhawan A (2013). Pharmacotherapy in Substance Use Disorder. In: Rakesh Lal, Sandhya Gupta (eds) Substance Use Disorders – Manual for Nursing Personnel, 2nd edition. New Delhi, Published by NDDTC, AIIMS, pp 25-45.
  • Dhawan A, Kumar A. Long term Pharmacotherapy of opioid dependence syndrome. In: RakeshLal (eds) Substance Use Disorders – Manual for Physicians, 2nd edition. New Delhi: Published by NDDTC, AIIMS; 2013: 77-85.
  • Dhawan A, Balhara YPS, Mohan I. Substance abuse in adolescents. In: Rakesh Lal (eds) Substance Use Disorders – Manual for Physicians, 2nd edition. New Delhi: Published by NDDTC, AIIMS; 2013: 191-198.
  • Sri Sri Ravi Shankar, Kenneth Paul Rosenberg, Anju Dhawan, AcharVedamurthachar. Meditation and Spirituality-Based Approaches for Addiction. In: Kenneth Paul Rosenberg, Laura Curtiss Feder (eds) Behavioral Addictions: Criteria, Evidence, and Treatment. UK: Published by Elsevier Inc; 2014: 343-360.
  • Renu Sharma, Mehta M, Dhawan A. Treatment of Substance Abusing Adolescents. In: Manju Mehta, Rajesh Sagar (eds) A Practical Approach to Cognitive Behaviour Therapy for Adolescents, New Delhi: Published by Springer; 2014: 331-361. ISBN 978-81-322-2241-5
  • Dhawan A, Pattanyak R (2014) Clinical Practice Guidelines on Management of Inhalant Use Disorders. In: Debashish Basu, PK Dalal (eds) Clinical Practice Guidelines for the Assessment and Management of Substance Use Disorders. Published by Indian Psychiatric Society.
  • Dhawan A, Pattanyak R (2015). Synopsis of the Clinical Practice Guidelines on Management of Inhalant Use Disorders. In: PK Dalal, Debashish Basu (eds) Synopsis of the Clinical Practice Guidelines on Substance Use Disorders. Published by Indian Psychiatric Society
  • Anju Dhawan, BiswadipChatterjee. Substance Use Disorders in Training handbook on counseling essential for staff of Child Care Institutions, published by NCPCR, New Delhi, 2016.
  • Dhawan A, Mongia M. Spirituality and Mental Health. In: RK Chadda, Vinay Kumar, Nitin Gupta, SiddharthSarkar (eds) Social Psychiatry: Principles and Clinical Perspective, New Delhi: Published by Jaypee Brothers; 2018: 133-140.
  • Dhawan A, Singh Shalini. Social Dimensions of Substance Use Disorders. In: RK Chadda, Vinay Kumar, Nitin Gupta, SiddharthSarkar (eds) Social Psychiatry: Principles and Clinical Perspective, New Delhi: Published by Jaypee Brothers; 2018: 217-226.
  • Dhawan A., Patil V., Gupta S., Chugh G. Mindfulness and Mental Health. In: Okpaku S.O.(eds) Innovations in Global Mental Health. Springer, Cham, 2021. https://doi.org/10.1007/978-3-319-70134-
  • Dhawan A, Mittal S. Spirituality and Mental Health. In: Rakesh Chadda, Pratap Sharan, Mamta Sood, Koushik Sinha Deb (eds), Mental Health at Cross-roads : Published by White Falcon Publishing 2022: page 229-233

Monographs/Books

  • Ray R, DhawanA, Ambekar A (2010). A manual for Quality Assurance of OST in Government Health Care settings, NACO.
  • Ray Rajat, Dhawan A, Ambekar A, Yadav D, Chopra A (2011). Coordination & convergence of Delhi District Health Services programmes & drug use intervention for the out of school children-Final Report. Submitted under the Government of India and WHO Collaborative Programme.
  • Ray Rajat, Dhawan A, Ambekar A, Jhanjhee S, Chopra A, Malhotra S (2011). Developing a network of de-addiction services from the Government, NGO & Private sector - Final Report. Submitted under the Government of India and WHO Collaborative Programme.
  • Ray R, Dhawan A, Ambekar A, Implementing OST: A Training Manual for service providers, DFID TAST and National AIDS Control Organisation, Government of India, New Delhi 2011.
  • Yadav D, Ambekar A, Dhawan A, Aggarwal A, Mehra J, Sethi H, OST program in Government health-care settings: treatment compliance and retention, report submitted to DFID TAST and NACO, Government of India 2011.
  • Report of the study on Assessment of pattern, profile and correlates of substance use among children in India. Conducted by NDDTC for the National Commission on Protection of Child Rights (NCPCR), India; 2013.
Default Doctor Image

Prof.
Vinay Goyal

Male

Affiliation

Department of
Neurology
Default Doctor Image

Prof.
Satish Jain

Male

Affiliation

Department of
Neurology
Default Woman Doctor Image

Prof.
Madhuri Behari

Female

Affiliation

Department of
Neurology
Fallback Doctor Image

Prof.
MC Maheshwari

Others

Affiliation

Department of
Neurology
Fallback Doctor Image

Prof.
GK Ahuja

Others

Affiliation

Department of
Neurology
Default Woman Doctor Image

Prof.
VimlaVirmani

Female

Affiliation

Department of
Neurology